| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of chromatin | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC5 H1-1 MACROH2A2 H2BC19P H2BC12 H2BC18 HP1BP3 | 8.87e-33 | 100 | 56 | 20 | GO:0030527 |
| GeneOntologyMolecularFunction | structural molecule activity | JPH1 H2BC12L RPL23A NEFH H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC5 H1-1 MACROH2A2 H2BC19P H2BC12 ADD2 H2BC18 ADD3 HP1BP3 | 1.86e-19 | 891 | 56 | 25 | GO:0005198 |
| GeneOntologyMolecularFunction | protein heterodimerization activity | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 MACROH2A2 H2BC19P H2BC12 ADD2 H2BC18 | 3.38e-12 | 398 | 56 | 14 | GO:0046982 |
| GeneOntologyMolecularFunction | nucleosome binding | 2.95e-10 | 98 | 56 | 8 | GO:0031491 | |
| GeneOntologyMolecularFunction | nucleosomal DNA binding | 7.07e-10 | 67 | 56 | 7 | GO:0031492 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 2.04e-08 | 167 | 56 | 8 | GO:0031490 | |
| GeneOntologyMolecularFunction | protein dimerization activity | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 MYO9B H2BC5 MACROH2A2 H2BC19P CEP57 H2BC12 ADD2 H2BC18 | 1.17e-07 | 1205 | 56 | 16 | GO:0046983 |
| GeneOntologyMolecularFunction | chromatin binding | MBD1 INSM1 H1-0 H1-2 H1-3 H1-4 H1-5 H1-1 MACROH2A2 PHF8 HP1BP3 NPM2 | 7.55e-07 | 739 | 56 | 12 | GO:0003682 |
| GeneOntologyMolecularFunction | STAT family protein binding | 5.91e-04 | 13 | 56 | 2 | GO:0097677 | |
| GeneOntologyMolecularFunction | dynein complex binding | 2.79e-03 | 28 | 56 | 2 | GO:0070840 | |
| GeneOntologyBiologicalProcess | nucleosome assembly | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-0 H1-2 H1-3 H1-4 H1-5 H1-1 MACROH2A2 HP1BP3 | 8.08e-22 | 122 | 53 | 15 | GO:0006334 |
| GeneOntologyBiologicalProcess | nucleosome organization | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-0 H1-2 H1-3 H1-4 H1-5 H1-1 MACROH2A2 HP1BP3 | 8.67e-21 | 142 | 53 | 15 | GO:0034728 |
| GeneOntologyBiologicalProcess | protein-DNA complex assembly | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-0 H1-2 H1-3 H1-4 H1-5 H1-1 MACROH2A2 HP1BP3 | 4.59e-17 | 249 | 53 | 15 | GO:0065004 |
| GeneOntologyBiologicalProcess | chromatin remodeling | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 MBD1 H1-0 H1-2 H1-3 H1-4 H1-5 H1-1 MACROH2A2 PHF8 HP1BP3 NPM2 | 1.61e-13 | 741 | 53 | 18 | GO:0006338 |
| GeneOntologyBiologicalProcess | chromatin organization | H2BC11 ATXN7L3 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 MBD1 H1-0 H1-2 H1-3 H1-4 H1-5 H1-1 MACROH2A2 PHF8 HP1BP3 NPM2 | 3.21e-13 | 896 | 53 | 19 | GO:0006325 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | H2BC11 ATXN7L3 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 MBD1 H1-0 H1-2 H1-3 H1-4 H1-5 H1-1 MACROH2A2 PHF8 HP1BP3 NPM2 | 2.19e-12 | 999 | 53 | 19 | GO:0071824 |
| GeneOntologyBiologicalProcess | innate immune response in mucosa | 1.22e-10 | 30 | 53 | 6 | GO:0002227 | |
| GeneOntologyBiologicalProcess | chromosome condensation | 2.43e-09 | 48 | 53 | 6 | GO:0030261 | |
| GeneOntologyBiologicalProcess | mucosal immune response | 2.43e-09 | 48 | 53 | 6 | GO:0002385 | |
| GeneOntologyBiologicalProcess | organ or tissue specific immune response | 5.05e-09 | 54 | 53 | 6 | GO:0002251 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA recombination | 5.66e-09 | 55 | 53 | 6 | GO:0045910 | |
| GeneOntologyBiologicalProcess | antibacterial humoral response | 8.05e-08 | 85 | 53 | 6 | GO:0019731 | |
| GeneOntologyBiologicalProcess | antimicrobial humoral immune response mediated by antimicrobial peptide | 1.20e-06 | 134 | 53 | 6 | GO:0061844 | |
| GeneOntologyBiologicalProcess | regulation of DNA recombination | 2.32e-06 | 150 | 53 | 6 | GO:0000018 | |
| GeneOntologyBiologicalProcess | defense response to Gram-positive bacterium | 2.32e-06 | 150 | 53 | 6 | GO:0050830 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA metabolic process | 2.80e-06 | 155 | 53 | 6 | GO:0051053 | |
| GeneOntologyBiologicalProcess | antimicrobial humoral response | 8.01e-06 | 186 | 53 | 6 | GO:0019730 | |
| GeneOntologyBiologicalProcess | regulation of DNA metabolic process | 1.22e-05 | 564 | 53 | 9 | GO:0051052 | |
| GeneOntologyBiologicalProcess | humoral immune response | 1.68e-04 | 321 | 53 | 6 | GO:0006959 | |
| GeneOntologyBiologicalProcess | establishment of protein localization to chromatin | 2.88e-04 | 10 | 53 | 2 | GO:0071169 | |
| GeneOntologyBiologicalProcess | chromosome organization | 3.39e-04 | 686 | 53 | 8 | GO:0051276 | |
| GeneOntologyBiologicalProcess | DNA recombination | 3.50e-04 | 368 | 53 | 6 | GO:0006310 | |
| GeneOntologyBiologicalProcess | defense response to bacterium | 5.81e-04 | 405 | 53 | 6 | GO:0042742 | |
| GeneOntologyBiologicalProcess | protein localization to chromatin | 6.25e-04 | 65 | 53 | 3 | GO:0071168 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic neurotransmitter receptor activity | 8.60e-04 | 17 | 53 | 2 | GO:0098962 | |
| GeneOntologyCellularComponent | nucleosome | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC5 H1-1 MACROH2A2 H2BC19P H2BC12 H2BC18 HP1BP3 | 5.82e-30 | 138 | 57 | 20 | GO:0000786 |
| GeneOntologyCellularComponent | chromatin | H2BC12L H2BC11 ATXN7L3 PPP1R10 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 HMX3 MBD1 H1-0 H1-2 YY2 H1-3 H1-4 H1-5 H2BC5 H1-1 MACROH2A2 H2BC19P H2BC12 H2BC18 HP1BP3 NPM2 | 1.46e-15 | 1480 | 57 | 26 | GO:0000785 |
| GeneOntologyCellularComponent | euchromatin | 4.26e-08 | 72 | 57 | 6 | GO:0000791 | |
| Domain | H2B | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC20P H2BC19P H2BC12 H2BC18 | 2.64e-26 | 21 | 54 | 12 | SM00427 |
| Domain | HISTONE_H2B | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC20P H2BC19P H2BC12 H2BC18 | 2.64e-26 | 21 | 54 | 12 | PS00357 |
| Domain | Histone_H2B | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC20P H2BC19P H2BC12 H2BC18 | 2.64e-26 | 21 | 54 | 12 | IPR000558 |
| Domain | Histone | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 MACROH2A2 H2BC20P H2BC19P H2BC12 H2BC18 | 3.56e-22 | 56 | 54 | 13 | PF00125 |
| Domain | Histone_H2A/H2B/H3 | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 MACROH2A2 H2BC20P H2BC19P H2BC12 H2BC18 | 3.56e-22 | 56 | 54 | 13 | IPR007125 |
| Domain | Histone-fold | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 MACROH2A2 H2BC20P H2BC19P H2BC12 H2BC18 | 9.44e-20 | 83 | 54 | 13 | IPR009072 |
| Domain | H15 | 1.91e-15 | 13 | 54 | 7 | SM00526 | |
| Domain | H15 | 1.91e-15 | 13 | 54 | 7 | PS51504 | |
| Domain | Linker_histone | 1.91e-15 | 13 | 54 | 7 | PF00538 | |
| Domain | Histone_H1/H5_H15 | 3.81e-15 | 14 | 54 | 7 | IPR005818 | |
| Domain | - | H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 MACROH2A2 H2BC12 H2BC18 | 5.05e-15 | 69 | 54 | 10 | 1.10.20.10 |
| Domain | Histone_H5 | 1.22e-14 | 8 | 54 | 6 | IPR005819 | |
| Domain | - | 2.98e-06 | 218 | 54 | 7 | 1.10.10.10 | |
| Domain | WHTH_DNA-bd_dom | 5.93e-06 | 242 | 54 | 7 | IPR011991 | |
| Domain | - | 4.90e-05 | 4 | 54 | 2 | 3.40.225.10 | |
| Domain | Aldolase_II/adducin_N | 4.90e-05 | 4 | 54 | 2 | IPR001303 | |
| Domain | Aldolase_II | 4.90e-05 | 4 | 54 | 2 | PF00596 | |
| Domain | Aldolase_II | 4.90e-05 | 4 | 54 | 2 | SM01007 | |
| Domain | RhoGAP | 1.39e-02 | 62 | 54 | 2 | SM00324 | |
| Domain | RhoGAP | 1.43e-02 | 63 | 54 | 2 | PF00620 | |
| Pathway | REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC5 H1-1 H2BC12 | 1.63e-25 | 79 | 46 | 16 | M27191 |
| Pathway | REACTOME_REPLACEMENT_OF_PROTAMINES_BY_NUCLEOSOMES_IN_THE_MALE_PRONUCLEUS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 NPM2 | 4.88e-19 | 42 | 46 | 11 | M48029 |
| Pathway | REACTOME_CELLULAR_SENESCENCE | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC5 H1-1 H2BC12 | 7.85e-19 | 197 | 46 | 16 | M27188 |
| Pathway | REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 PHF8 H2BC12 | 3.78e-16 | 73 | 46 | 11 | M27166 |
| Pathway | REACTOME_RECOGNITION_AND_ASSOCIATION_OF_DNA_GLYCOSYLASE_WITH_SITE_CONTAINING_AN_AFFECTED_PURINE | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 1.26e-15 | 55 | 46 | 10 | M29526 |
| Pathway | REACTOME_BASE_EXCISION_REPAIR_AP_SITE_FORMATION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 4.56e-15 | 62 | 46 | 10 | M27700 |
| Pathway | REACTOME_DNA_METHYLATION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 6.40e-15 | 64 | 46 | 10 | M27429 |
| Pathway | REACTOME_ACTIVATED_PKN1_STIMULATES_TRANSCRIPTION_OF_AR_ANDROGEN_RECEPTOR_REGULATED_GENES_KLK2_AND_KLK3 | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 8.87e-15 | 66 | 46 | 10 | M27488 |
| Pathway | REACTOME_SIRT1_NEGATIVELY_REGULATES_RRNA_EXPRESSION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 1.04e-14 | 67 | 46 | 10 | M27342 |
| Pathway | REACTOME_INHIBITION_OF_DNA_RECOMBINATION_AT_TELOMERE | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 1.04e-14 | 67 | 46 | 10 | M39003 |
| Pathway | REACTOME_ASSEMBLY_OF_THE_ORC_COMPLEX_AT_THE_ORIGIN_OF_REPLICATION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 1.22e-14 | 68 | 46 | 10 | M27658 |
| Pathway | REACTOME_NONHOMOLOGOUS_END_JOINING_NHEJ | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 1.22e-14 | 68 | 46 | 10 | M27587 |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_THE_HUMAN_SILENCING_HUB_HUSH_COMPLEX | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 1.65e-14 | 70 | 46 | 10 | M48261 |
| Pathway | REACTOME_CHROMATIN_MODIFICATIONS_DURING_THE_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 1.65e-14 | 70 | 46 | 10 | M48028 |
| Pathway | REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 2.22e-14 | 72 | 46 | 10 | M29714 |
| Pathway | REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 2.22e-14 | 72 | 46 | 10 | M27132 |
| Pathway | REACTOME_ERCC6_CSB_AND_EHMT2_G9A_POSITIVELY_REGULATE_RRNA_EXPRESSION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 3.41e-14 | 75 | 46 | 10 | M27343 |
| Pathway | REACTOME_MEIOTIC_SYNAPSIS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 5.14e-14 | 78 | 46 | 10 | M1061 |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 5.14e-14 | 78 | 46 | 10 | M27589 |
| Pathway | REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE | 8.71e-14 | 54 | 46 | 9 | MM14904 | |
| Pathway | REACTOME_MEIOTIC_RECOMBINATION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 1.80e-13 | 88 | 46 | 10 | M1011 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_GRANULOPOIESIS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 2.03e-13 | 89 | 46 | 10 | M27943 |
| Pathway | REACTOME_BASE_EXCISION_REPAIR | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 2.27e-13 | 90 | 46 | 10 | M2158 |
| Pathway | REACTOME_RNA_POLYMERASE_I_PROMOTER_ESCAPE | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 2.27e-13 | 90 | 46 | 10 | M27691 |
| Pathway | REACTOME_B_WICH_COMPLEX_POSITIVELY_REGULATES_RRNA_EXPRESSION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 2.27e-13 | 90 | 46 | 10 | M29668 |
| Pathway | REACTOME_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 NPM2 | 2.28e-13 | 128 | 46 | 11 | M48019 |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 2.55e-13 | 91 | 46 | 10 | M27101 |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PKNS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 3.19e-13 | 93 | 46 | 10 | M27487 |
| Pathway | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 3.56e-13 | 94 | 46 | 10 | M1080 |
| Pathway | REACTOME_HDACS_DEACETYLATE_HISTONES | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 H2BC18 | 3.56e-13 | 94 | 46 | 10 | M27230 |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 4.42e-13 | 96 | 46 | 10 | M27792 |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 4.92e-13 | 97 | 46 | 10 | M48262 |
| Pathway | REACTOME_PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 4.92e-13 | 97 | 46 | 10 | M27590 |
| Pathway | KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 MACROH2A2 H2BC12 H2BC18 | 5.70e-13 | 139 | 46 | 11 | M4741 |
| Pathway | REACTOME_MITOTIC_PROPHASE | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 PHF8 H2BC12 | 7.23e-13 | 142 | 46 | 11 | M27660 |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | H2BC11 ATXN7L3 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 H2BC18 | 7.23e-13 | 142 | 46 | 11 | M27233 |
| Pathway | REACTOME_DISEASES_OF_PROGRAMMED_CELL_DEATH | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 1.00e-12 | 104 | 46 | 10 | M29829 |
| Pathway | REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 1.11e-12 | 105 | 46 | 10 | M27425 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 1.22e-12 | 106 | 46 | 10 | M27458 |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_KRAB_ZFP_PROTEINS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 1.34e-12 | 107 | 46 | 10 | M48260 |
| Pathway | REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION | 1.45e-12 | 13 | 46 | 6 | M1018 | |
| Pathway | REACTOME_NEGATIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 1.48e-12 | 108 | 46 | 10 | M27426 |
| Pathway | REACTOME_AMYLOID_FIBER_FORMATION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 1.78e-12 | 110 | 46 | 10 | M27958 |
| Pathway | REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 1.78e-12 | 110 | 46 | 10 | M27696 |
| Pathway | REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 1.95e-12 | 111 | 46 | 10 | M27187 |
| Pathway | WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 2.14e-12 | 112 | 46 | 10 | M48334 |
| Pathway | REACTOME_TELOMERE_MAINTENANCE | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 2.14e-12 | 112 | 46 | 10 | M4052 |
| Pathway | REACTOME_HCMV_LATE_EVENTS | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 H2BC18 | 3.05e-12 | 116 | 46 | 10 | M29806 |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 3.95e-12 | 119 | 46 | 10 | M607 |
| Pathway | REACTOME_MEIOSIS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 4.30e-12 | 120 | 46 | 10 | M529 |
| Pathway | REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 5.08e-12 | 122 | 46 | 10 | M29689 |
| Pathway | REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 6.49e-12 | 125 | 46 | 10 | M27186 |
| Pathway | REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 8.92e-12 | 129 | 46 | 10 | M27795 |
| Pathway | REACTOME_FORMATION_OF_SENESCENCE_ASSOCIATED_HETEROCHROMATIN_FOCI_SAHF | 1.04e-11 | 17 | 46 | 6 | M27189 | |
| Pathway | REACTOME_E3_UBIQUITIN_LIGASES_UBIQUITINATE_TARGET_PROTEINS | 1.33e-11 | 59 | 46 | 8 | M27763 | |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 H2BC18 | 1.76e-11 | 138 | 46 | 10 | M29805 |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 1.89e-11 | 139 | 46 | 10 | M715 |
| Pathway | REACTOME_CHROMOSOME_MAINTENANCE | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 1.89e-11 | 139 | 46 | 10 | M868 |
| Pathway | REACTOME_HOMOLOGY_DIRECTED_REPAIR | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 2.03e-11 | 140 | 46 | 10 | M27584 |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 2.34e-11 | 142 | 46 | 10 | M48257 |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 3.78e-11 | 149 | 46 | 10 | M27888 |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | H2BC11 ATXN7L3 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 PHF8 H2BC12 H2BC18 | 4.54e-11 | 272 | 46 | 12 | M29619 |
| Pathway | REACTOME_REPRODUCTION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 6.77e-11 | 158 | 46 | 10 | M26956 |
| Pathway | REACTOME_DNA_REPLICATION_PRE_INITIATION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 7.21e-11 | 159 | 46 | 10 | M27665 |
| Pathway | REACTOME_HCMV_INFECTION | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 H2BC18 | 8.68e-11 | 162 | 46 | 10 | M29804 |
| Pathway | REACTOME_G2_M_CHECKPOINTS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 1.17e-10 | 167 | 46 | 10 | M19381 |
| Pathway | REACTOME_CELLULAR_SENESCENCE | 1.36e-10 | 119 | 46 | 9 | MM14901 | |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 1.40e-10 | 170 | 46 | 10 | M27582 |
| Pathway | REACTOME_PROTEIN_UBIQUITINATION | 1.49e-10 | 79 | 46 | 8 | M27742 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 APC H2BC5 H2BC12 | 1.59e-10 | 233 | 46 | 11 | M27099 |
| Pathway | REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION | 2.30e-10 | 12 | 46 | 5 | MM14554 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 MDK H2BC12 | 2.85e-10 | 246 | 46 | 11 | M10189 |
| Pathway | REACTOME_APOPTOTIC_EXECUTION_PHASE | 2.93e-10 | 52 | 46 | 7 | M2341 | |
| Pathway | REACTOME_CELLULAR_RESPONSES_TO_STIMULI | H2BC12L RPL23A H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC5 H1-1 H2BC12 | 3.50e-10 | 828 | 46 | 17 | M27827 |
| Pathway | REACTOME_DNA_REPLICATION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 3.57e-10 | 187 | 46 | 10 | M1017 |
| Pathway | REACTOME_FORMATION_OF_SENESCENCE_ASSOCIATED_HETEROCHROMATIN_FOCI_SAHF | 8.67e-10 | 15 | 46 | 5 | MM14902 | |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 1.74e-09 | 220 | 46 | 10 | M27794 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 H2BC18 | 1.82e-09 | 221 | 46 | 10 | M27578 |
| Pathway | REACTOME_DEUBIQUITINATION | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 APC H2BC5 H2BC12 H2BC18 | 2.24e-09 | 299 | 46 | 11 | M27574 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 3.58e-09 | 237 | 46 | 10 | M27786 |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 MYO9B RAPGEF1 H2BC5 SPEN ARHGAP21 H2BC12 ADD3 | 4.22e-09 | 720 | 46 | 15 | M41838 |
| Pathway | REACTOME_M_PHASE | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 PHF8 CEP57 H2BC12 | 6.00e-09 | 417 | 46 | 12 | M27662 |
| Pathway | REACTOME_SIGNALING_BY_WNT | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 APC H2BC5 H2BC12 | 6.29e-09 | 330 | 46 | 11 | M7847 |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 6.97e-09 | 254 | 46 | 10 | M27131 |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | 7.31e-09 | 46 | 46 | 6 | MM14935 | |
| Pathway | REACTOME_APOPTOTIC_EXECUTION_PHASE | 1.08e-08 | 49 | 46 | 6 | MM15448 | |
| Pathway | REACTOME_HDACS_DEACETYLATE_HISTONES | 2.21e-08 | 55 | 46 | 6 | MM14932 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 2.55e-08 | 291 | 46 | 10 | M16647 |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 2.99e-08 | 296 | 46 | 10 | M27869 |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 6.81e-08 | 323 | 46 | 10 | M27080 |
| Pathway | REACTOME_DNA_REPAIR | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 8.80e-08 | 332 | 46 | 10 | M15434 |
| Pathway | REACTOME_CELL_CYCLE_MITOTIC | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 PHF8 CEP57 H2BC12 | 1.58e-07 | 561 | 46 | 12 | M5336 |
| Pathway | REACTOME_APOPTOSIS | 1.28e-06 | 108 | 46 | 6 | MM14471 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 1.43e-06 | 175 | 46 | 7 | MM14941 | |
| Pathway | REACTOME_CELL_CYCLE | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 PHF8 CEP57 H2BC12 | 1.53e-06 | 694 | 46 | 12 | M543 |
| Pathway | REACTOME_APOPTOSIS | 1.67e-06 | 179 | 46 | 7 | M15303 | |
| Pathway | REACTOME_INHIBITION_OF_DNA_RECOMBINATION_AT_TELOMERE | 2.93e-06 | 31 | 46 | 4 | MM17225 | |
| Pathway | REACTOME_PROGRAMMED_CELL_DEATH | 4.97e-06 | 211 | 46 | 7 | M27436 | |
| Pathway | REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES | 6.06e-06 | 37 | 46 | 4 | MM14883 | |
| Pathway | REACTOME_PROGRAMMED_CELL_DEATH | 6.32e-06 | 142 | 46 | 6 | MM15178 | |
| Pubmed | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-2 H1-3 H1-4 H1-5 H2BC5 H1-1 H2BC20P H2BC19P H2BC12 H2BC18 | 2.03e-32 | 77 | 58 | 17 | 12408966 | |
| Pubmed | Inhibition of core histones acetylation by carcinogenic nickel(II). | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC20P H2BC19P H2BC12 H2BC18 | 2.52e-30 | 18 | 58 | 12 | 16283522 |
| Pubmed | Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile twenty kinase. | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC20P H2BC19P H2BC12 H2BC18 | 2.52e-30 | 18 | 58 | 12 | 12757711 |
| Pubmed | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC12 H2BC18 | 4.66e-23 | 22 | 58 | 10 | 16713563 | |
| Pubmed | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC12 H2BC18 | 8.24e-23 | 23 | 58 | 10 | 16307923 | |
| Pubmed | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-2 H1-3 H1-4 H1-5 KRI1 H2BC5 H1-1 H2BC12 H2BC18 | 1.88e-22 | 277 | 58 | 17 | 30745168 | |
| Pubmed | Quantitative proteomic analysis of post-translational modifications of human histones. | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC12 | 1.25e-21 | 17 | 58 | 9 | 16627869 |
| Pubmed | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC12 H2BC18 | 2.15e-21 | 30 | 58 | 10 | 16319397 | |
| Pubmed | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H1-2 H1-3 H1-4 H1-5 H2BC5 | 1.15e-20 | 55 | 58 | 11 | 9439656 | |
| Pubmed | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-2 H1-4 H2BC5 H2BC12 | 1.21e-19 | 67 | 58 | 11 | 25253489 | |
| Pubmed | H2BC13 H2BC15 H2BC9 H2BC4 H1-2 H1-3 H1-4 H1-5 H2BC5 H1-1 H2BC12 | 2.94e-18 | 88 | 58 | 11 | 26318153 | |
| Pubmed | H2BC12L RPL23A H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 MYO9B MBD1 H1-2 H1-3 H1-4 H2BC5 H1-1 H2BC20P H2BC19P H2BC12 H2BC18 | 3.12e-18 | 844 | 58 | 20 | 25963833 | |
| Pubmed | RPL23A H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC5 H2BC12 H2BC18 | 9.34e-18 | 425 | 58 | 16 | 21081503 | |
| Pubmed | Hormone-mediated dephosphorylation of specific histone H1 isoforms. | 1.65e-17 | 6 | 58 | 6 | 11479299 | |
| Pubmed | Linker histone transitions during mammalian oogenesis and embryogenesis. | 1.65e-17 | 6 | 58 | 6 | 9499577 | |
| Pubmed | H1 family histones in the nucleus. Control of binding and localization by the C-terminal domain. | 1.65e-17 | 6 | 58 | 6 | 15911621 | |
| Pubmed | Enhancement of the p300 HAT activity by HIV-1 Tat on chromatin DNA. | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 MACROH2A2 H2BC12 | 2.31e-17 | 69 | 58 | 10 | 11689053 |
| Pubmed | RPL23A H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H1-2 H1-3 H1-4 H2BC5 H1-1 H2BC12 H2BC18 | 2.74e-17 | 212 | 58 | 13 | 23463506 | |
| Pubmed | RPL23A H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 NHSL2 TRO H1-0 H1-2 H1-3 H1-4 H1-5 H2BC5 H1-1 ZBTB11 SPEN CEP57 ARHGAP21 H2BC12 H2BC18 HP1BP3 | 2.96e-17 | 1442 | 58 | 23 | 35575683 | |
| Pubmed | 4.20e-17 | 13 | 58 | 7 | 8858344 | ||
| Pubmed | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 MACROH2A2 H2BC12 | 4.20e-17 | 73 | 58 | 10 | 14657027 | |
| Pubmed | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 MACROH2A2 H2BC12 | 4.20e-17 | 73 | 58 | 10 | 9566873 | |
| Pubmed | All known human H1 histone genes except the H1(0) gene are clustered on chromosome 6. | 1.15e-16 | 7 | 58 | 6 | 8325638 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | H2BC12L RPL23A H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-0 H1-2 H1-4 H1-5 H2BC5 SRRM2 H2BC12 H2BC18 | 1.76e-16 | 626 | 58 | 17 | 33644029 |
| Pubmed | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 MACROH2A2 H2BC12 | 2.36e-16 | 86 | 58 | 10 | 11080476 | |
| Pubmed | Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC20P H2BC19P H2BC12 H2BC18 | 7.94e-16 | 203 | 58 | 12 | 16916647 |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | H2BC12L RPL23A H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H1-3 H1-4 H2BC5 PPFIA3 SRRM2 H2BC12 H2BC18 | 1.59e-15 | 477 | 58 | 15 | 31300519 |
| Pubmed | Dynamic changes in H1 subtype composition during epigenetic reprogramming. | 3.44e-15 | 10 | 58 | 6 | 28794128 | |
| Pubmed | 7.56e-15 | 11 | 58 | 6 | 15197225 | ||
| Pubmed | Role of H1 linker histones in mammalian development and stem cell differentiation. | 7.56e-15 | 11 | 58 | 6 | 26689747 | |
| Pubmed | Histone modifications associated with somatic hypermutation. | 7.56e-15 | 11 | 58 | 6 | 16039583 | |
| Pubmed | The mouse histone H1 genes: gene organization and differential regulation. | 1.08e-14 | 5 | 58 | 5 | 9300059 | |
| Pubmed | 1.08e-14 | 5 | 58 | 5 | 11467742 | ||
| Pubmed | A proposal for a coherent mammalian histone H1 nomenclature correlated with amino acid sequences. | 1.08e-14 | 5 | 58 | 5 | 8003976 | |
| Pubmed | Expression of murine H1 histone genes during postnatal development. | 1.08e-14 | 5 | 58 | 5 | 9655912 | |
| Pubmed | A unified phylogeny-based nomenclature for histone variants. | 1.51e-14 | 12 | 58 | 6 | 22650316 | |
| Pubmed | H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H1-2 H1-3 H1-4 H2BC5 H2BC12 H2BC18 ADD3 HP1BP3 | 1.88e-14 | 451 | 58 | 14 | 36168627 | |
| Pubmed | Characterization of phosphorylation sites on histone H1 isoforms by tandem mass spectrometry. | 6.48e-14 | 6 | 58 | 5 | 15595731 | |
| Pubmed | 6.48e-14 | 6 | 58 | 5 | 15562002 | ||
| Pubmed | The multifunctional protein nucleophosmin (NPM1) is a human linker histone H1 chaperone. | 6.48e-14 | 6 | 58 | 5 | 21425800 | |
| Pubmed | Histone H2B as a functionally important plasminogen receptor on macrophages. | 8.15e-14 | 15 | 58 | 6 | 17690254 | |
| Pubmed | Human histone gene organization: nonregular arrangement within a large cluster. | 1.60e-13 | 35 | 58 | 7 | 9119399 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | H2BC12L PPP1R10 H2BC13 H2BC15 H2BC9 TCF20 H1-2 YY2 KRI1 H2BC5 MDK SRRM2 SPEN ZNF281 H2BC12 H2BC18 HP1BP3 | 1.68e-13 | 954 | 58 | 17 | 36373674 |
| Pubmed | RPL23A H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-2 H1-3 H1-4 KRI1 H2BC5 H1-1 PHF8 H2BC12 H2BC18 HP1BP3 | 2.64e-13 | 1153 | 58 | 18 | 29845934 | |
| Pubmed | RPL23A H2BC11 H2BC13 H2BC15 H2BC9 H1-2 H1-3 H1-5 H2BC5 H1-1 H2BC18 | 3.15e-13 | 247 | 58 | 11 | 30713523 | |
| Pubmed | Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants. | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 H2BC18 | 4.65e-13 | 256 | 58 | 11 | 35777956 |
| Pubmed | Interactome study suggests multiple cellular functions of hepatoma-derived growth factor (HDGF). | H2BC4 H2BC21 H1-0 H1-2 H1-3 H1-4 H2BC5 MACROH2A2 H2BC12 HP1BP3 | 8.17e-13 | 191 | 58 | 10 | 21907836 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | RPL23A ATXN7L3 PPP1R10 H2BC15 H2BC9 TCF20 MBD1 H1-0 H1-2 H1-4 H1-5 H2BC5 PHF8 SRRM2 SPEN ZNF281 H2BC12 HP1BP3 | 1.82e-12 | 1294 | 58 | 18 | 30804502 |
| Pubmed | High-throughput kinase assays with protein substrates using fluorescent polymer superquenching. | 2.71e-12 | 10 | 58 | 5 | 15927069 | |
| Pubmed | H2BC12L RPL23A H2BC11 H2BC13 H2BC15 H1-0 H1-2 H1-4 H1-5 H2BC5 H2BC19P SRRM2 H2BC12 HP1BP3 | 2.74e-12 | 652 | 58 | 14 | 31180492 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | RPL23A H2BC11 H2BC13 H2BC15 H2BC4 H2BC17 NHSL2 TRO H1-2 H1-3 H1-4 H1-5 H2BC5 H1-1 H2BC12 | 6.25e-12 | 847 | 58 | 15 | 35235311 |
| Pubmed | 6.96e-12 | 4 | 58 | 4 | 19072710 | ||
| Pubmed | H1 linker histones are essential for mouse development and affect nucleosome spacing in vivo. | 6.96e-12 | 4 | 58 | 4 | 12808097 | |
| Pubmed | 6.96e-12 | 4 | 58 | 4 | 11746507 | ||
| Pubmed | 6.96e-12 | 4 | 58 | 4 | 10997781 | ||
| Pubmed | Isolation of two murine H1 histone genes and chromosomal mapping of the H1 gene complement. | 6.96e-12 | 4 | 58 | 4 | 8589518 | |
| Pubmed | 6.96e-12 | 4 | 58 | 4 | 11689686 | ||
| Pubmed | Regulation of error-prone translesion synthesis by Spartan/C1orf124. | 7.86e-12 | 59 | 58 | 7 | 23254330 | |
| Pubmed | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H1-2 H1-3 H1-4 H1-5 H2BC5 H1-1 H2BC12 H2BC18 | 1.04e-11 | 878 | 58 | 15 | 37223481 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 H2BC18 | 2.62e-11 | 271 | 58 | 10 | 32433965 |
| Pubmed | Characterization of the histone H1-binding protein, NASP, as a cell cycle-regulated somatic protein. | 3.48e-11 | 5 | 58 | 4 | 10893414 | |
| Pubmed | Endotoxin-neutralizing antimicrobial proteins of the human placenta. | 3.48e-11 | 5 | 58 | 4 | 11859126 | |
| Pubmed | Biochemical and antibacterial analysis of human wound and blister fluid. | 3.48e-11 | 5 | 58 | 4 | 8620898 | |
| Pubmed | 4.07e-11 | 74 | 58 | 7 | 36180920 | ||
| Pubmed | 4.66e-11 | 16 | 58 | 5 | 33288900 | ||
| Pubmed | RPL23A H2BC11 H2BC13 TCF20 H1-3 H1-4 KRI1 H1-1 ZBTB11 SRRM2 SPEN RBM34 HP1BP3 | 4.66e-11 | 653 | 58 | 13 | 22586326 | |
| Pubmed | Antimicrobial peptides in the first line defence of human colon mucosa. | 9.11e-11 | 18 | 58 | 5 | 12860195 | |
| Pubmed | H2BC13 H2BC15 H2BC17 H2BC21 H1-2 H1-3 H1-4 H1-5 H2BC5 RBM34 H2BC12 | 9.33e-11 | 419 | 58 | 11 | 15635413 | |
| Pubmed | Gene-specific characterization of human histone H2B by electron capture dissociation. | 1.04e-10 | 6 | 58 | 4 | 16457587 | |
| Pubmed | 1.04e-10 | 6 | 58 | 4 | 19882353 | ||
| Pubmed | 1.04e-10 | 6 | 58 | 4 | 12686141 | ||
| Pubmed | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 H2BC18 | 1.49e-10 | 438 | 58 | 11 | 21630459 | |
| Pubmed | RPL23A H2BC21 H1-0 H1-2 H1-3 H1-4 KRI1 H2BC5 MACROH2A2 SRRM2 SPEN RBM34 HP1BP3 | 1.86e-10 | 731 | 58 | 13 | 29298432 | |
| Pubmed | 2.43e-10 | 7 | 58 | 4 | 24435047 | ||
| Pubmed | 2.43e-10 | 7 | 58 | 4 | 15019208 | ||
| Pubmed | 3.26e-10 | 99 | 58 | 7 | 34161765 | ||
| Pubmed | 3.48e-10 | 250 | 58 | 9 | 33536335 | ||
| Pubmed | RPL23A PPP1R10 H2BC15 H2BC21 TULP4 H1-0 H1-2 H1-1 PHF8 SRRM2 RBM34 HP1BP3 | 3.57e-10 | 615 | 58 | 12 | 31048545 | |
| Pubmed | RPL23A H2BC13 H2BC15 H2BC9 H2BC4 H1-2 H1-3 H1-5 H2BC5 H2BC18 HP1BP3 | 4.98e-10 | 491 | 58 | 11 | 22623428 | |
| Pubmed | 1.89e-09 | 205 | 58 | 8 | 27976729 | ||
| Pubmed | 2.85e-09 | 216 | 58 | 8 | 37640791 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | JPH1 RPL23A H2BC11 H2BC4 H2BC21 H1-0 H1-2 H1-3 H1-4 H1-5 SRRM2 H2BC12 HP1BP3 | 4.34e-09 | 949 | 58 | 13 | 36574265 |
| Pubmed | 4.40e-09 | 3 | 58 | 3 | 26209608 | ||
| Pubmed | Prevalence and architecture of de novo mutations in developmental disorders. | 4.40e-09 | 3 | 58 | 3 | 28135719 | |
| Pubmed | 4.40e-09 | 3 | 58 | 3 | 2613692 | ||
| Pubmed | High-resolution mapping of h1 linker histone variants in embryonic stem cells. | 4.40e-09 | 3 | 58 | 3 | 23633960 | |
| Pubmed | 4.40e-09 | 3 | 58 | 3 | 24525734 | ||
| Pubmed | 4.40e-09 | 3 | 58 | 3 | 21245380 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 4.83e-09 | 231 | 58 | 8 | 16452087 | |
| Pubmed | H2BC11 PPP1R10 H2BC13 H2BC15 H2BC9 H2BC17 H1-3 H1-4 H1-5 H2BC5 H2BC12 | 5.83e-09 | 622 | 58 | 11 | 14574404 | |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | 6.43e-09 | 349 | 58 | 9 | 25665578 | |
| Pubmed | 6.88e-09 | 14 | 58 | 4 | 10064132 | ||
| Pubmed | RPL23A H2BC11 H1-2 H1-4 KRI1 MACROH2A2 ARHGAP21 RBM34 H2BC12 HP1BP3 | 6.99e-09 | 483 | 58 | 10 | 36912080 | |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 8.62e-09 | 361 | 58 | 9 | 30344098 | |
| Pubmed | 9.37e-09 | 15 | 58 | 4 | 28190768 | ||
| Pubmed | RPL23A H1-0 H1-2 H1-3 H1-4 H1-5 H2BC5 ZBTB11 SRRM2 RBM34 HP1BP3 | 9.93e-09 | 655 | 58 | 11 | 35819319 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | MYO9B H1-0 H1-3 MACROH2A2 PHF8 ZBTB11 SRRM2 ZNF281 H2BC18 HP1BP3 | 1.77e-08 | 533 | 58 | 10 | 30554943 |
| Pubmed | 5.38e-08 | 206 | 58 | 7 | 22174317 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 5.81e-08 | 605 | 58 | 10 | 28977666 | |
| Pubmed | 7.48e-08 | 329 | 58 | 8 | 17474147 | ||
| Interaction | H2AC12 interactions | H2BC11 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC5 H1-1 H2BC12 H2BC18 HP1BP3 | 3.15e-23 | 118 | 57 | 16 | int:H2AC12 |
| Interaction | H2AC6 interactions | H2BC11 H2BC13 H2BC15 H2BC4 H2BC17 H2BC21 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC5 H1-1 H2BC12 H2BC18 | 1.69e-22 | 100 | 57 | 15 | int:H2AC6 |
| Interaction | H2AC7 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-2 H1-3 H1-4 H1-5 H2BC5 H1-1 H2BC12 H2BC18 | 4.97e-22 | 107 | 57 | 15 | int:H2AC7 |
| Interaction | H2BC18 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 TRO DLGAP4 H1-2 H1-4 H1-5 H2BC5 H1-1 RBM34 H2BC12 H2BC18 | 6.95e-22 | 180 | 57 | 17 | int:H2BC18 |
| Interaction | H2AC25 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H1-2 H1-3 H1-4 H1-5 H2BC5 H1-1 H2BC12 H2BC18 | 1.02e-21 | 84 | 57 | 14 | int:H2AC25 |
| Interaction | H3-5 interactions | H2BC11 H2BC13 H2BC9 H2BC21 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC5 H1-1 MACROH2A2 PHF8 H2BC12 HP1BP3 | 1.35e-21 | 114 | 57 | 15 | int:H3-5 |
| Interaction | H3C15 interactions | H2BC11 H2BC13 H2BC9 H2BC4 H2BC21 TRO H1-0 H1-2 H1-3 H1-4 H1-5 H2BC5 H1-1 MACROH2A2 SRRM2 H2BC12 HP1BP3 | 7.89e-21 | 207 | 57 | 17 | int:H3C15 |
| Interaction | CDK5R2 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 H2BC18 | 1.58e-20 | 23 | 57 | 10 | int:CDK5R2 |
| Interaction | H2AC13 interactions | H2BC11 H2BC13 H2BC15 H2BC17 H2BC21 H1-2 H1-3 H1-4 H1-5 H2BC5 H1-1 H2BC12 H2BC18 | 1.89e-20 | 75 | 57 | 13 | int:H2AC13 |
| Interaction | HMGN2 interactions | RPL23A H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-2 H1-4 H1-5 H2BC5 H1-1 MACROH2A2 PHF8 H2BC12 H2BC18 | 2.64e-20 | 222 | 57 | 17 | int:HMGN2 |
| Interaction | H2AC14 interactions | H2BC11 H2BC15 H2BC9 H2BC17 H2BC21 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC5 H1-1 H2BC20P H2BC12 H2BC18 | 5.23e-20 | 144 | 57 | 15 | int:H2AC14 |
| Interaction | H2AC18 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-2 H1-3 H1-4 H1-5 H2BC5 H1-1 H2BC12 H2BC18 | 7.99e-20 | 148 | 57 | 15 | int:H2AC18 |
| Interaction | H2AC11 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-2 H1-3 H1-4 H1-5 H2BC5 H1-1 MACROH2A2 RBM34 H2BC12 H2BC18 | 1.77e-19 | 248 | 57 | 17 | int:H2AC11 |
| Interaction | H2BC21 interactions | H2BC11 ATXN7L3 PPP1R10 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 TCF20 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC5 H1-1 MACROH2A2 PHF8 SRRM2 H2BC12 H2BC18 HP1BP3 | 2.95e-19 | 696 | 57 | 23 | int:H2BC21 |
| Interaction | H2BC9 interactions | RPL23A H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 TRO DLGAP4 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC5 H1-1 ZBTB11 H2BC12 H2BC18 | 2.96e-19 | 446 | 57 | 20 | int:H2BC9 |
| Interaction | H2BC12 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 TRO H1-0 H1-2 H1-3 H1-4 H2BC5 MACROH2A2 ZBTB11 H2BC12 H2BC18 HP1BP3 | 5.06e-19 | 322 | 57 | 18 | int:H2BC12 |
| Interaction | CYLC1 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC12 H2BC18 | 9.78e-19 | 20 | 57 | 9 | int:CYLC1 |
| Interaction | HMGA1 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 TCF20 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC5 MACROH2A2 H2BC20P SPEN H2BC12 H2BC18 HP1BP3 | 2.25e-18 | 419 | 57 | 19 | int:HMGA1 |
| Interaction | TNN interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC12 H2BC18 | 4.73e-18 | 23 | 57 | 9 | int:TNN |
| Interaction | H2BC4 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 TRO H1-2 H1-3 H2BC5 MACROH2A2 SRRM2 H2BC12 H2BC18 HP1BP3 | 1.26e-17 | 259 | 57 | 16 | int:H2BC4 |
| Interaction | HMGN3 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 MYO9B H2BC5 H2BC12 H2BC18 | 2.21e-17 | 64 | 57 | 11 | int:HMGN3 |
| Interaction | H2AC4 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 TCF20 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC5 H1-1 H2BC20P H2BC12 H2BC18 HP1BP3 | 7.45e-17 | 506 | 57 | 19 | int:H2AC4 |
| Interaction | DUOX2 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC12 H2BC18 | 8.16e-17 | 30 | 57 | 9 | int:DUOX2 |
| Interaction | H2AC21 interactions | RPL23A H2BC11 H2BC15 H2BC9 H2BC17 H2BC21 H1-0 H1-2 H1-4 H1-5 H2BC5 H1-1 MACROH2A2 RBM34 H2BC18 | 8.57e-17 | 234 | 57 | 15 | int:H2AC21 |
| Interaction | H2BC26 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-0 H1-4 KRI1 H2BC5 MACROH2A2 H2BC12 H2BC18 | 8.58e-17 | 183 | 57 | 14 | int:H2BC26 |
| Interaction | TTN interactions | JPH1 H2BC13 H2BC9 H2BC4 H2BC17 H2BC21 H1-2 H1-4 H1-5 KRI1 H2BC5 H1-1 SPEN CEP57 H2BC12 H2BC18 | 1.24e-16 | 299 | 57 | 16 | int:TTN |
| Interaction | H3-3A interactions | H2BC11 PPP1R10 H2BC13 H2BC9 H2BC4 H2BC21 TCF20 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC5 H1-1 PHF8 ZBTB11 SPEN ZNF281 RBM34 H2BC12 HP1BP3 | 4.31e-16 | 749 | 57 | 21 | int:H3-3A |
| Interaction | MCM5 interactions | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-2 H1-3 H1-4 H2BC5 H1-1 H2BC20P H2BC19P H2BC12 H2BC18 | 1.25e-15 | 420 | 57 | 17 | int:MCM5 |
| Interaction | H3C1 interactions | H2BC11 H2BC13 H2BC9 H2BC4 H2BC17 H2BC21 H1-0 H1-2 H1-3 H1-4 H1-5 KRI1 H2BC5 H1-1 MACROH2A2 PHF8 SPEN ZNF281 RBM34 H2BC12 H2BC18 HP1BP3 | 1.25e-15 | 901 | 57 | 22 | int:H3C1 |
| Interaction | FAM47B interactions | 1.67e-15 | 13 | 57 | 7 | int:FAM47B | |
| Interaction | LOC102724334 interactions | RPL23A H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 DLGAP4 H2BC5 H2BC12 H2BC18 | 2.48e-15 | 134 | 57 | 12 | int:LOC102724334 |
| Interaction | JPH2 interactions | 2.56e-15 | 25 | 57 | 8 | int:JPH2 | |
| Interaction | H2AZ1 interactions | H2BC11 H2BC13 H2BC9 H2BC4 H2BC17 H2BC21 TCF20 H1-0 H1-2 H2BC5 H1-1 MACROH2A2 H2BC20P H2BC12 H2BC18 HP1BP3 | 3.68e-15 | 371 | 57 | 16 | int:H2AZ1 |
| Interaction | ZNF474 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC12 H2BC18 | 3.92e-15 | 44 | 57 | 9 | int:ZNF474 |
| Interaction | PCLO interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H1-1 H2BC12 H2BC18 | 4.96e-15 | 70 | 57 | 10 | int:PCLO |
| Interaction | H2BC5 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-2 H1-3 H1-4 H1-5 H2BC5 SRRM2 H2BC12 H2BC18 | 1.47e-14 | 331 | 57 | 15 | int:H2BC5 |
| Interaction | H2BC13 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-3 H1-5 H2BC5 SRRM2 H2BC12 H2BC18 | 1.92e-14 | 210 | 57 | 13 | int:H2BC13 |
| Interaction | H2AX interactions | RPL23A H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-2 H1-4 KRI1 H2BC5 H1-1 H2BC20P ZBTB11 SRRM2 H2BC12 H2BC18 | 2.26e-14 | 593 | 57 | 18 | int:H2AX |
| Interaction | TEX35 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC12 H2BC18 | 4.84e-14 | 57 | 57 | 9 | int:TEX35 |
| Interaction | PSMD14 interactions | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-2 H1-3 H1-4 H1-5 KRI1 H2BC5 H1-1 H2BC12 H2BC18 | 5.14e-14 | 527 | 57 | 17 | int:PSMD14 |
| Interaction | H1-3 interactions | H2BC13 H2BC9 H2BC4 H2BC21 H1-0 H1-2 H1-3 H1-4 H1-5 KRI1 H2BC5 H1-1 RBM34 H2BC12 | 5.53e-14 | 291 | 57 | 14 | int:H1-3 |
| Interaction | H1-6 interactions | H2BC15 H2BC9 H2BC4 H2BC21 H1-2 H1-3 H1-4 H1-5 KRI1 H1-1 RBM34 H2BC12 HP1BP3 | 5.89e-14 | 229 | 57 | 13 | int:H1-6 |
| Interaction | RPS27A interactions | RPL23A H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-2 H1-3 H1-4 H2BC5 H1-1 MACROH2A2 MDK H2BC12 H2BC18 | 6.77e-14 | 536 | 57 | 17 | int:RPS27A |
| Interaction | H3-4 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC21 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC5 H1-1 H2BC20P PHF8 H2BC12 | 6.85e-14 | 448 | 57 | 16 | int:H3-4 |
| Interaction | H2BC1 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 TCF20 H2BC5 MACROH2A2 H2BC12 H2BC18 | 7.76e-14 | 178 | 57 | 12 | int:H2BC1 |
| Interaction | IGSF8 interactions | RPL23A H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H1-2 H1-3 H1-4 H2BC5 H1-1 H2BC12 H2BC18 | 1.02e-13 | 239 | 57 | 13 | int:IGSF8 |
| Interaction | H1-5 interactions | RPL23A H2BC13 H2BC9 H2BC21 MYO9B H1-0 H1-2 H1-3 H1-4 H1-5 H2BC5 H1-1 PHF8 TSKS H2BC18 HP1BP3 | 1.14e-13 | 463 | 57 | 16 | int:H1-5 |
| Interaction | H1-4 interactions | RPL23A H2BC9 H2BC21 H1-0 H1-2 H1-3 H1-4 H1-5 KRI1 H2BC5 H1-1 PHF8 TSKS ZBTB11 RBM34 H2BC12 H2BC18 HP1BP3 | 1.27e-13 | 656 | 57 | 18 | int:H1-4 |
| Interaction | H1-2 interactions | RPL23A H2BC9 H2BC4 H2BC21 MYO9B H1-0 H1-2 H1-3 H1-4 H1-5 KRI1 H2BC5 H1-1 H2BC20P TSKS H2BC12 H2BC18 HP1BP3 | 1.64e-13 | 666 | 57 | 18 | int:H1-2 |
| Interaction | DPPA2 interactions | 1.76e-13 | 40 | 57 | 8 | int:DPPA2 | |
| Interaction | ICAM1 interactions | RPL23A H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H1-2 H1-3 H1-4 H2BC5 H1-1 H2BC12 H2BC18 | 2.01e-13 | 252 | 57 | 13 | int:ICAM1 |
| Interaction | H2AC20 interactions | H2BC11 ATXN7L3 H2BC15 H2BC9 H2BC17 H2BC21 TCF20 H1-4 KRI1 H2BC5 H1-1 H2BC12 H2BC18 HP1BP3 | 2.03e-13 | 320 | 57 | 14 | int:H2AC20 |
| Interaction | HMGN4 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 MACROH2A2 H2BC12 H2BC18 | 2.03e-13 | 100 | 57 | 10 | int:HMGN4 |
| Interaction | H2BC15 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 MACROH2A2 H2BC12 H2BC18 | 2.34e-13 | 144 | 57 | 11 | int:H2BC15 |
| Interaction | HCLS1 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC12 H2BC18 | 3.89e-13 | 71 | 57 | 9 | int:HCLS1 |
| Interaction | H1-1 interactions | NEFH H2BC9 H2BC21 H1-0 H1-2 H1-3 H1-4 H1-5 KRI1 H1-1 MDK TSKS ZBTB11 RBM34 H2BC18 HP1BP3 | 4.56e-13 | 507 | 57 | 16 | int:H1-1 |
| Interaction | LARP7 interactions | RPL23A H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-2 H1-3 H1-4 H1-5 KRI1 H2BC5 H1-1 MACROH2A2 PHF8 ZBTB11 H2BC12 H2BC18 HP1BP3 | 1.01e-12 | 1113 | 57 | 21 | int:LARP7 |
| Interaction | CD81 interactions | RPL23A H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H1-2 H1-3 H1-4 H2BC5 H1-1 H2BC12 H2BC18 | 2.10e-12 | 303 | 57 | 13 | int:CD81 |
| Interaction | RIOK1 interactions | RPL23A H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC5 H2BC12 H2BC18 | 2.18e-12 | 562 | 57 | 16 | int:RIOK1 |
| Interaction | HEXIM1 interactions | RPL23A H2BC11 PPP1R10 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-2 H1-3 H1-4 KRI1 H2BC5 H1-1 MACROH2A2 H2BC12 H2BC18 HP1BP3 | 3.03e-12 | 913 | 57 | 19 | int:HEXIM1 |
| Interaction | SFMBT2 interactions | 3.15e-12 | 32 | 57 | 7 | int:SFMBT2 | |
| Interaction | BTF3 interactions | H2BC12L RPL23A H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-0 H1-2 H1-4 H1-5 H2BC5 H1-1 SRRM2 H2BC12 H2BC18 | 3.51e-12 | 799 | 57 | 18 | int:BTF3 |
| Interaction | H2BC11 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 MACROH2A2 H2BC12 H2BC18 | 3.92e-12 | 186 | 57 | 11 | int:H2BC11 |
| Interaction | ADARB1 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 TCF20 H2BC5 H1-1 ZBTB11 RBM34 H2BC12 H2BC18 HP1BP3 | 4.16e-12 | 489 | 57 | 15 | int:ADARB1 |
| Interaction | H2AB3 interactions | H2BC11 H2BC13 H2BC15 H1-0 H1-2 H1-3 KRI1 ZBTB11 H2BC12 HP1BP3 | 4.62e-12 | 136 | 57 | 10 | int:H2AB3 |
| Interaction | H3-7 interactions | H2BC13 H2BC9 H2BC21 H1-2 H1-3 H1-4 H1-5 H2BC5 H1-1 MACROH2A2 | 4.97e-12 | 137 | 57 | 10 | int:H3-7 |
| Interaction | H2BC17 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 H2BC18 | 6.18e-12 | 140 | 57 | 10 | int:H2BC17 |
| Interaction | H2BC14 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC12 H2BC18 | 9.33e-12 | 100 | 57 | 9 | int:H2BC14 |
| Interaction | UBA52 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-2 H1-3 H1-4 H2BC5 H1-1 H2BC12 H2BC18 | 1.36e-11 | 437 | 57 | 14 | int:UBA52 |
| Interaction | SMC5 interactions | H2BC12L PPP1R10 H2BC13 H2BC15 H2BC9 TCF20 H1-2 YY2 H1-5 KRI1 H2BC5 H1-1 MDK SRRM2 SPEN ZNF281 H2BC12 H2BC18 HP1BP3 | 1.48e-11 | 1000 | 57 | 19 | int:SMC5 |
| Interaction | TAAR3P interactions | 1.89e-11 | 9 | 57 | 5 | int:TAAR3P | |
| Interaction | CHD4 interactions | RPL23A H2BC13 H2BC9 H2BC21 TCF20 H1-0 H1-2 H1-4 KRI1 H2BC5 H1-1 MACROH2A2 H2BC20P SRRM2 SPEN RBM34 H2BC12 HP1BP3 | 4.98e-11 | 938 | 57 | 18 | int:CHD4 |
| Interaction | ARHGAP24 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H1-2 H1-3 H1-4 H2BC5 H2BC12 H2BC18 ADD3 HP1BP3 | 5.57e-11 | 486 | 57 | 14 | int:ARHGAP24 |
| Interaction | MCM2 interactions | H2BC12L RPL23A H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 MYO9B MBD1 H1-0 H1-2 H1-4 H2BC5 H1-1 MACROH2A2 H2BC12 H2BC18 | 5.65e-11 | 1081 | 57 | 19 | int:MCM2 |
| Interaction | PDS5B interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H1-1 H2BC12 H2BC18 | 6.76e-11 | 178 | 57 | 10 | int:PDS5B |
| Interaction | PLA2G4F interactions | 6.90e-11 | 11 | 57 | 5 | int:PLA2G4F | |
| Interaction | HDGF interactions | H2BC4 H2BC21 H1-0 H1-2 H1-3 H1-4 H2BC5 H1-1 MACROH2A2 SPEN H2BC12 HP1BP3 | 8.09e-11 | 321 | 57 | 12 | int:HDGF |
| Interaction | H2AJ interactions | 8.20e-11 | 127 | 57 | 9 | int:H2AJ | |
| Interaction | PRKCB interactions | H2BC11 H2BC13 H2BC15 H2BC21 H1-0 H1-2 H1-4 H1-5 H2BC5 H1-1 H2BC12 | 1.18e-10 | 255 | 57 | 11 | int:PRKCB |
| Interaction | MEPCE interactions | RPL23A H2BC11 PPP1R10 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-2 H1-3 H1-4 H2BC5 H1-1 H2BC12 H2BC18 HP1BP3 | 1.21e-10 | 859 | 57 | 17 | int:MEPCE |
| Interaction | H1-0 interactions | H2BC9 H2BC21 H1-0 H1-2 H1-3 H1-4 H1-5 H1-1 MACROH2A2 H2BC12 HP1BP3 | 1.24e-10 | 256 | 57 | 11 | int:H1-0 |
| Interaction | ZCRB1 interactions | 1.33e-10 | 134 | 57 | 9 | int:ZCRB1 | |
| Interaction | TNRC18 interactions | 1.90e-10 | 92 | 57 | 8 | int:TNRC18 | |
| Interaction | KNOP1 interactions | RPL23A H2BC13 H2BC15 H2BC4 H2BC17 H1-3 H2BC5 H1-1 RBM34 H2BC12 H2BC18 | 2.36e-10 | 272 | 57 | 11 | int:KNOP1 |
| Interaction | DAXX interactions | RPL23A H2BC11 H2BC13 H2BC21 H1-2 H1-5 KRI1 H1-1 ZBTB11 SRRM2 SPEN HP1BP3 | 2.41e-10 | 353 | 57 | 12 | int:DAXX |
| Interaction | PINK1 interactions | H2BC12L RPL23A H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H1-3 H1-4 H2BC5 PPFIA3 SRRM2 H2BC12 H2BC18 | 4.16e-10 | 679 | 57 | 15 | int:PINK1 |
| Interaction | KRR1 interactions | RPL23A H2BC11 H1-2 H1-3 H1-4 H1-5 KRI1 H2BC5 H1-1 ZBTB11 RBM34 HP1BP3 | 5.43e-10 | 379 | 57 | 12 | int:KRR1 |
| Interaction | RBM19 interactions | RPL23A H1-2 H1-3 H1-4 H1-5 KRI1 H1-1 MACROH2A2 ZBTB11 HP1BP3 | 5.65e-10 | 221 | 57 | 10 | int:RBM19 |
| Interaction | HMGN1 interactions | 1.00e-09 | 168 | 57 | 9 | int:HMGN1 | |
| Interaction | H2AC1 interactions | 1.14e-09 | 71 | 57 | 7 | int:H2AC1 | |
| Interaction | H2BC3 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 TCF20 H1-2 H2BC5 H2BC12 H2BC18 | 1.19e-09 | 406 | 57 | 12 | int:H2BC3 |
| Interaction | GLYR1 interactions | 1.21e-09 | 239 | 57 | 10 | int:GLYR1 | |
| Interaction | TSKS interactions | 1.39e-09 | 40 | 57 | 6 | int:TSKS | |
| Interaction | USF3 interactions | 2.27e-09 | 20 | 57 | 5 | int:USF3 | |
| Interaction | MAP1B interactions | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-0 H2BC5 SRRM2 H2BC12 H2BC18 | 2.59e-09 | 539 | 57 | 13 | int:MAP1B |
| Interaction | REXO4 interactions | 2.83e-09 | 261 | 57 | 10 | int:REXO4 | |
| Interaction | TMEM196 interactions | 3.99e-09 | 8 | 57 | 4 | int:TMEM196 | |
| Interaction | PYHIN1 interactions | RPL23A TCF20 MBD1 H1-0 H1-2 H1-4 KRI1 MACROH2A2 SRRM2 SPEN HP1BP3 | 4.24e-09 | 358 | 57 | 11 | int:PYHIN1 |
| Interaction | SCAF1 interactions | 4.37e-09 | 136 | 57 | 8 | int:SCAF1 | |
| Interaction | MACROH2A1 interactions | H2BC15 H2BC9 H2BC4 H2BC21 H1-0 H1-2 H1-4 H1-1 MACROH2A2 PHF8 ZBTB11 H2BC12 | 4.61e-09 | 458 | 57 | 12 | int:MACROH2A1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6p22 | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H1-2 H1-3 H1-4 H1-5 H2BC5 H1-1 H2BC12 | 1.47e-15 | 378 | 58 | 13 | chr6p22 |
| Cytoband | 6p22.1 | 2.79e-08 | 142 | 58 | 6 | 6p22.1 | |
| Cytoband | 6p21.3 | 3.10e-08 | 250 | 58 | 7 | 6p21.3 | |
| Cytoband | 1q21.2 | 2.09e-06 | 71 | 58 | 4 | 1q21.2 | |
| Cytoband | 10q26.13 | 1.07e-03 | 38 | 58 | 2 | 10q26.13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q21 | 1.72e-03 | 404 | 58 | 4 | chr1q21 | |
| GeneFamily | Histones | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H1-0 H1-2 H1-3 H1-4 H1-5 H2BC5 H1-1 MACROH2A2 H2BC20P H2BC19P H2BC12 H2BC18 | 1.14e-33 | 116 | 42 | 20 | 864 |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_14_PRECICTIVE_ICB_RESPONSE | 1.27e-11 | 198 | 56 | 10 | MM17083 | |
| Coexpression | MARSON_BOUND_BY_E2F4_UNSTIMULATED | H2BC11 H2BC13 H2BC9 H2BC4 H2BC17 MYO9B H1-3 H1-5 H2BC5 H1-1 CEP57 H2BC12 H2BC18 | 2.62e-09 | 714 | 56 | 13 | M1744 |
| Coexpression | NUYTTEN_NIPP1_TARGETS_UP | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 TCF20 CCDC138 H1-2 H1-4 H2BC5 H2BC12 | 6.27e-09 | 768 | 56 | 13 | M6444 |
| Coexpression | GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_24H_DN | 1.04e-08 | 200 | 56 | 8 | M9952 | |
| Coexpression | ZHENG_CORD_BLOOD_C5_SIMILAR_TO_HSC_C6_PUTATIVE_ALTERED_METABOLIC_STATE | 6.14e-08 | 97 | 56 | 6 | M39214 | |
| Coexpression | GSE43260_BTLA_POS_VS_NEG_INTRATUMORAL_CD8_TCELL_DN | 2.21e-07 | 199 | 56 | 7 | M9954 | |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_UP | 1.95e-06 | 96 | 56 | 5 | M1683 | |
| Coexpression | EGFR_UP.V1_DN | 3.85e-06 | 196 | 56 | 6 | M2633 | |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_UP | 4.00e-06 | 111 | 56 | 5 | MM705 | |
| Coexpression | GSE29618_MONOCYTE_VS_MDC_DN | 4.33e-06 | 200 | 56 | 6 | M4949 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_CYCLING_DEFINITIVE_ERYTHROBLAST | 4.90e-06 | 450 | 56 | 8 | M45747 | |
| Coexpression | DANG_BOUND_BY_MYC | H2BC12L H2BC11 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 MBD1 INSM1 APC SRRM2 | 1.27e-05 | 1061 | 56 | 11 | M15774 |
| Coexpression | HASLINGER_B_CLL_WITH_6Q21_DELETION | 1.38e-05 | 22 | 56 | 3 | M7362 | |
| Coexpression | KENNEDY_PBMC_DRYVAX_AGE_18_50YO_STIMULATED_VS_UNSTIMULATED_1_TO_48MO_TOP_DEG_UP | 1.38e-05 | 22 | 56 | 3 | M41188 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_PLATELET_CELL | 1.72e-05 | 384 | 56 | 7 | M45735 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_EARLY_FIBROBLAST | 2.75e-05 | 81 | 56 | 4 | M45667 | |
| Coexpression | FISCHER_DREAM_TARGETS | PPP1R10 H2BC13 H2BC9 H2BC4 H2BC17 H2BC21 H1-2 H1-3 H1-5 CEP57 | 3.46e-05 | 969 | 56 | 10 | M149 |
| Coexpression | MARSON_BOUND_BY_FOXP3_UNSTIMULATED | H2BC11 H2BC13 H2BC4 H2BC17 H1-4 H1-5 KRI1 H2BC5 H2BC12 H2BC18 HP1BP3 | 5.28e-05 | 1239 | 56 | 11 | M1743 |
| Coexpression | JONES_OVARY_GRANULOSA | 5.36e-05 | 96 | 56 | 4 | M48347 | |
| Coexpression | GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_17H_UP | 5.51e-05 | 191 | 56 | 5 | M8742 | |
| Coexpression | GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_UP | 6.08e-05 | 195 | 56 | 5 | M3184 | |
| Coexpression | GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_VA24NEG_NKTCELL_DN | 6.38e-05 | 197 | 56 | 5 | M8303 | |
| Coexpression | BENPORATH_CYCLING_GENES | 6.67e-05 | 648 | 56 | 8 | M8156 | |
| Coexpression | GSE33292_WT_VS_TCF1_KO_DN3_THYMOCYTE_UP | 6.69e-05 | 199 | 56 | 5 | M9420 | |
| Coexpression | GSE14769_40MIN_VS_360MIN_LPS_BMDM_DN | 6.69e-05 | 199 | 56 | 5 | M3517 | |
| Coexpression | GSE12845_IGD_POS_VS_NEG_BLOOD_BCELL_UP | 6.69e-05 | 199 | 56 | 5 | M3182 | |
| Coexpression | KOBAYASHI_EGFR_SIGNALING_24HR_UP | 6.80e-05 | 102 | 56 | 4 | M10290 | |
| Coexpression | GSE29618_MONOCYTE_VS_MDC_DAY7_FLU_VACCINE_DN | 6.85e-05 | 200 | 56 | 5 | M4968 | |
| Coexpression | BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP | 8.63e-05 | 40 | 56 | 3 | M15147 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_NK_CELL | 1.07e-04 | 694 | 56 | 8 | M45767 | |
| Coexpression | ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN | 1.12e-04 | 222 | 56 | 5 | M16955 | |
| Coexpression | DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP | 1.32e-04 | 368 | 56 | 6 | M16431 | |
| Coexpression | UDAYAKUMAR_MED1_TARGETS_DN | 1.74e-04 | 244 | 56 | 5 | M9945 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_SCHWANN_CELL_AGEING | 2.00e-04 | 10 | 56 | 2 | MM3742 | |
| Coexpression | TRAVAGLINI_LUNG_PLATELET_MEGAKARYOCYTE_CELL | 2.93e-04 | 605 | 56 | 7 | M41691 | |
| Coexpression | MARSON_BOUND_BY_FOXP3_STIMULATED | 2.97e-04 | 1024 | 56 | 9 | M1742 | |
| Coexpression | ZHAN_MULTIPLE_MYELOMA_UP | 3.51e-04 | 64 | 56 | 3 | M3958 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_UP | 3.58e-04 | 443 | 56 | 6 | M40870 | |
| Coexpression | STEINER_ERYTHROCYTE_MEMBRANE_GENES | 4.01e-04 | 14 | 56 | 2 | M2442 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_UP | 4.12e-04 | 163 | 56 | 4 | M8235 | |
| Coexpression | CAIRO_LIVER_DEVELOPMENT_UP | 4.41e-04 | 166 | 56 | 4 | M17163 | |
| Coexpression | CAIRO_LIVER_DEVELOPMENT_UP | 4.51e-04 | 167 | 56 | 4 | MM1057 | |
| Coexpression | HAY_BONE_MARROW_PRO_B | 4.78e-04 | 304 | 56 | 5 | M39208 | |
| Coexpression | GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN | 4.95e-04 | 471 | 56 | 6 | M19016 | |
| Coexpression | TRAVAGLINI_LUNG_PROLIFERATING_BASAL_CELL | 5.78e-04 | 891 | 56 | 8 | M41654 | |
| Coexpression | PRC2_EED_DN.V1_UP | 7.46e-04 | 191 | 56 | 4 | M2736 | |
| Coexpression | HOXA9_DN.V1_UP | 7.61e-04 | 192 | 56 | 4 | M2850 | |
| Coexpression | LAIHO_COLORECTAL_CANCER_SERRATED_DN | 8.06e-04 | 85 | 56 | 3 | M17423 | |
| Coexpression | GSE29618_BCELL_VS_MONOCYTE_UP | 8.06e-04 | 195 | 56 | 4 | M4936 | |
| Coexpression | GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_6H_UP | 8.06e-04 | 195 | 56 | 4 | M8739 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL | 8.15e-04 | 939 | 56 | 8 | M45768 | |
| Coexpression | GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_12MO_CORRELATED_WITH_ANTIBODY_RESPONSE_NEGATIVE | 8.31e-04 | 20 | 56 | 2 | M41044 | |
| Coexpression | GSE19401_PLN_VS_PEYERS_PATCH_FOLLICULAR_DC_DN | 8.70e-04 | 199 | 56 | 4 | M7667 | |
| Coexpression | GSE26030_TH1_VS_TH17_RESTIMULATED_DAY15_POST_POLARIZATION_UP | 8.70e-04 | 199 | 56 | 4 | M8580 | |
| Coexpression | GSE15930_STIM_VS_STIM_AND_IFNAB_72H_CD8_T_CELL_UP | 8.70e-04 | 199 | 56 | 4 | M3641 | |
| Coexpression | GSE26351_WNT_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP | 8.70e-04 | 199 | 56 | 4 | M8477 | |
| Coexpression | GSE20198_IL12_VS_IFNA_TREATED_ACT_CD4_TCELL_DN | 8.70e-04 | 199 | 56 | 4 | M7374 | |
| Coexpression | GSE36009_WT_VS_NLRP10_KO_DC_LPS_STIM_DN | 8.70e-04 | 199 | 56 | 4 | M8770 | |
| Coexpression | GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_NK_CELL_DN | 8.86e-04 | 200 | 56 | 4 | M9411 | |
| Coexpression | GSE34205_HEALTHY_VS_FLU_INF_INFANT_PBMC_DN | 8.86e-04 | 200 | 56 | 4 | M5139 | |
| Coexpression | GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD4_TCELL_DN | 8.86e-04 | 200 | 56 | 4 | M4664 | |
| Coexpression | GSE9650_NAIVE_VS_EXHAUSTED_CD8_TCELL_DN | 8.86e-04 | 200 | 56 | 4 | M5828 | |
| Coexpression | FISCHER_G1_S_CELL_CYCLE | 8.86e-04 | 200 | 56 | 4 | M107 | |
| Coexpression | GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_PDC_DN | 8.86e-04 | 200 | 56 | 4 | M5019 | |
| Coexpression | GSE9650_GP33_VS_GP276_LCMV_SPECIFIC_EXHAUSTED_CD8_TCELL_UP | 8.86e-04 | 200 | 56 | 4 | M5842 | |
| Coexpression | GSE22886_CTRL_VS_LPS_24H_DC_DN | 8.86e-04 | 200 | 56 | 4 | M4520 | |
| Coexpression | GSE36392_MAC_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP | 8.86e-04 | 200 | 56 | 4 | M5285 | |
| Coexpression | GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_60H_DN | 8.86e-04 | 200 | 56 | 4 | M9688 | |
| Coexpression | GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_CD8_TCELL_UP | 8.86e-04 | 200 | 56 | 4 | M3587 | |
| Coexpression | GSE14350_TREG_VS_TEFF_IN_IL2RB_KO_UP | 8.86e-04 | 200 | 56 | 4 | M3419 | |
| Coexpression | GSE19923_WT_VS_HEB_KO_DP_THYMOCYTE_UP | 8.86e-04 | 200 | 56 | 4 | M7279 | |
| Coexpression | GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_CD8_TCELL_UP | 8.86e-04 | 200 | 56 | 4 | M3605 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_EFF_MEMORY_CD4_TCELL_UP | 8.86e-04 | 200 | 56 | 4 | M5416 | |
| Coexpression | GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP | 8.86e-04 | 200 | 56 | 4 | M4456 | |
| CoexpressionAtlas | mendel_RNAseq_e17.5_Urothelium_ShhCreRFP_2500_K3 | 2.03e-08 | 32 | 56 | 5 | mendel_RNAseq_e17.5_Urothelium_ShhCreRFP_2500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500_K4 | 2.94e-08 | 70 | 56 | 6 | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_MandArch_2500_K1 | 3.78e-08 | 125 | 56 | 7 | facebase_RNAseq_e9.5_MandArch_2500_K1 | |
| CoexpressionAtlas | gudmap_RNAseq_e11.5_Ureteric_bud_2500_K2 | 2.06e-07 | 50 | 56 | 5 | gudmap_RNAseq_e11.5_Ureteric_bud_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_500_k-means-cluster#3 | 3.97e-07 | 108 | 56 | 6 | Facebase_RNAseq_e9.5_Olfactory Placode_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#3 | 4.43e-07 | 110 | 56 | 6 | Facebase_RNAseq_e9.5_Mandibular Arch_500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_ParaxMesoderm_2500_K0 | 4.43e-07 | 110 | 56 | 6 | facebase_RNAseq_e8.5_ParaxMesoderm_2500_K0 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.14e-06 | 300 | 56 | 8 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K1 | 1.30e-06 | 72 | 56 | 5 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.61e-06 | 137 | 56 | 6 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_500_k-means-cluster#1 | 2.20e-06 | 80 | 56 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_500_K1 | |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Mesangium_2500_K4 | 4.26e-06 | 162 | 56 | 6 | gudmap_RNAseq_e15.5_Mesangium_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_500 | 4.36e-06 | 482 | 56 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_500 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_MaxArch_2500_K4 | H2BC11 H2BC13 H2BC15 H2BC17 H1-2 H1-3 H1-4 H1-5 H2BC5 H1-1 MDK H2BC12 H2BC18 | 5.43e-06 | 1125 | 56 | 13 | facebase_RNAseq_e9.5_MaxArch_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#4 | 7.64e-06 | 275 | 56 | 7 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_MaxArch_2500 | H2BC11 H2BC13 H2BC15 H2BC17 H1-2 H1-3 H1-4 H1-5 H2BC5 H1-1 MDK H2BC12 ADD2 H2BC18 | 9.13e-06 | 1371 | 56 | 14 | facebase_RNAseq_e9.5_MaxArch_2500 |
| CoexpressionAtlas | facebase_RNAseq_e9.5_FaceMes_2500_K2 | 1.24e-05 | 54 | 56 | 4 | facebase_RNAseq_e9.5_FaceMes_2500_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K4 | 1.66e-05 | 58 | 56 | 4 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K4 | |
| CoexpressionAtlas | EB amniotic fluid MSC_vs_EB blastocyst-Confounder_removed-fold2.0_adjp0.05 | H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 NRXN2 INSM1 H2BC5 H2BC12 ADD2 | 1.78e-05 | 727 | 56 | 10 | PCBC_ratio_EB amniotic fluid MSC_vs_EB blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#4 | 2.64e-05 | 133 | 56 | 5 | Facebase_RNAseq_e9.5_Maxillary Arch_500_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K2 | 5.84e-05 | 157 | 56 | 5 | facebase_RNAseq_e8.5_FloorPlate_2500_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_ParaxMesoderm_2500 | H2BC11 H2BC13 H2BC15 H2BC17 NHSL2 H1-2 H1-3 H1-4 H1-5 H2BC5 H1-1 H2BC12 H2BC18 | 6.80e-05 | 1429 | 56 | 13 | facebase_RNAseq_e8.5_ParaxMesoderm_2500 |
| CoexpressionAtlas | facebase_RNAseq_e9.5_FaceMes_2500 | H2BC11 H2BC13 H2BC15 H2BC17 H1-2 H1-3 H1-4 H1-5 H2BC5 H1-1 H2BC12 H2BC18 | 6.81e-05 | 1226 | 56 | 12 | facebase_RNAseq_e9.5_FaceMes_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#5 | 7.18e-05 | 164 | 56 | 5 | Facebase_RNAseq_e9.5_Maxillary Arch_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#3 | 7.31e-05 | 268 | 56 | 6 | Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_OlfacPit_2500 | H2BC11 H2BC13 H2BC15 H2BC17 H1-0 H1-4 H1-5 APC H2BC5 MDK H2BC12 ADD2 H2BC18 | 8.06e-05 | 1453 | 56 | 13 | facebase_RNAseq_e10.5_OlfacPit_2500 |
| CoexpressionAtlas | bone marrow | 1.17e-04 | 292 | 56 | 6 | bone marrow | |
| CoexpressionAtlas | ECTO amniotic fluid MSC_vs_ECTO blastocyst-Confounder_removed-fold2.0_adjp0.05 | 1.20e-04 | 183 | 56 | 5 | PCBC_ratio_ECTO amniotic fluid MSC_vs_ECTO blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Podocytes_2500_K1 | 1.99e-04 | 43 | 56 | 3 | gudmap_RNAseq_e15.5_Podocytes_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000 | 2.14e-04 | 979 | 56 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_500 | 2.95e-04 | 491 | 56 | 7 | Facebase_RNAseq_e9.5_Olfactory Placode_500 | |
| CoexpressionAtlas | gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K1 | 3.50e-04 | 52 | 56 | 3 | gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 3.57e-04 | 359 | 56 | 6 | Facebase_RNAseq_e9.5_Mandibular Arch_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000_k-means-cluster#1 | 3.91e-04 | 236 | 56 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_500_k-means-cluster#1 | 4.08e-04 | 132 | 56 | 4 | Facebase_RNAseq_e9.5_Facial Mesenchyne_500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000_k-means-cluster#2 | 6.28e-04 | 148 | 56 | 4 | Facebase_RNAseq_e9.5_Facial Mesenchyne_1000_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_OlfacPit_2500_K1 | 6.48e-04 | 402 | 56 | 6 | facebase_RNAseq_e10.5_OlfacPit_2500_K1 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg1+vd6+.Th.TCRbko, TCRd+ Vg1.1+ Vd6.3+, Thymus, avg-3 | 8.75e-04 | 71 | 56 | 3 | GSM605778_100 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_FaceMes_2500_K4 | 1.00e-03 | 983 | 56 | 9 | facebase_RNAseq_e9.5_FaceMes_2500_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500 | H2BC11 H2BC13 H2BC15 H2BC17 H1-4 H2BC5 H1-1 ZNF281 H2BC12 H2BC18 | 1.07e-03 | 1202 | 56 | 10 | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg1+vd6-.Th.TCRbko, TCRd+ Vg1.1+, Thymus, avg-3 | 1.19e-03 | 79 | 56 | 3 | GSM605784_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.27e-03 | 629 | 56 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.40e-03 | 828 | 56 | 8 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K1 | |
| CoexpressionAtlas | mendel_RNAseq_e12.5_Urothelium_ShhCreRFP_2500_K3 | 1.58e-03 | 1266 | 56 | 10 | mendel_RNAseq_e12.5_Urothelium_ShhCreRFP_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_500 | 1.67e-03 | 483 | 56 | 6 | Facebase_RNAseq_e9.5_Maxillary Arch_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_500 | 1.68e-03 | 484 | 56 | 6 | Facebase_RNAseq_e9.5_Mandibular Arch_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg1+vd6+.Th.TCRbko, TCRd+ Vg1.1+ Vd6.3+, Thymus, avg-3 | 1.69e-03 | 327 | 56 | 5 | GSM605778_500 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-12 | 186 | 58 | 9 | 4ed1b97e2552f3c4134f25665d7513498ffac16c | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-12 | 186 | 58 | 9 | 15ab6666748a641226e42e6ca6eeaf186a501c95 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Plasmacytoid_Dendritic_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.02e-11 | 171 | 58 | 8 | 39c8ae139e449217091e1481eb5e2aafb8f69a1c | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_dendritic-plasmacytoid_dendritic_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.19e-09 | 167 | 58 | 7 | afb6d0993f3fd44a295874673055189d514f7b11 | |
| ToppCell | COVID-19_Severe|World / disease group, cell group and cell class | 6.66e-09 | 196 | 58 | 7 | 3bedf60f662b373ad9d0f07d4da9f11864af3a74 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2|World / Primary Cells by Cluster | 7.66e-09 | 200 | 58 | 7 | 4923d7a4f00853c4d76fc1cc0fa82d522a2302e7 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2-5|World / Primary Cells by Cluster | 7.66e-09 | 200 | 58 | 7 | dc1c1506823eaa105f1532c6b5d4efa14e788314 | |
| ToppCell | facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Lymphocytic-B_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.16e-08 | 170 | 58 | 6 | 4ab2a890c8631028ee9099d2faf6091c742a317b | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c11-MKI67-FOS|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.24e-07 | 179 | 58 | 6 | ac987c9425a1b4106d1b8779a2c5461383eae2ae | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.28e-07 | 180 | 58 | 6 | 5568063c2518fadb638e665635061ec10d00fb6a | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.28e-07 | 180 | 58 | 6 | 1be264962fd4ed0bb59f9b8a6956c4239ca32e05 | |
| ToppCell | 356C-Lymphocytic-Plasma_cell|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.33e-07 | 181 | 58 | 6 | f1d88b83a13acd1c8e6b9ff8bd0acaff3650ceef | |
| ToppCell | 356C-Lymphocytic-Plasma_cell-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.33e-07 | 181 | 58 | 6 | 70cd612706640d8ebf0e047582b1daa2c1121526 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mast-Mast-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.33e-07 | 181 | 58 | 6 | c35ca98c474e31917e0a53c092397e0d8d18b37c | |
| ToppCell | Lymphoid-Lymphoid-T_cells_(cycle)|Lymphoid / shred on cell class and cell subclass (v4) | 1.33e-07 | 181 | 58 | 6 | b6b41cd5d43543fe7a093033dae52a789199db0e | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.51e-07 | 185 | 58 | 6 | 89b85ce8026dc80c1bd9f76dfe16401c173b7946 | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-Proliferating_T_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.51e-07 | 185 | 58 | 6 | 0e0f043ad6d2a62cd47ce39911ad81feab4a4d7e | |
| ToppCell | mild_COVID-19_(asymptomatic)-Platelet|World / disease group, cell group and cell class (v2) | 1.77e-07 | 190 | 58 | 6 | 7aaf82f0c235363afb95cf1fa51c2a5b070b1af8 | |
| ToppCell | PCW_07-8.5|World / Celltypes from embryonic and fetal-stage human lung | 2.00e-07 | 194 | 58 | 6 | 5759c83308df017f1faae248e9b85388e25254f0 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.06e-07 | 195 | 58 | 6 | 027075e9c62b5754a014a9d1393e1b0f5ae42e41 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.06e-07 | 195 | 58 | 6 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Myeloid-Megakaryocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.06e-07 | 195 | 58 | 6 | 1bcc0c8b1281396b1433ce5a2ec8681de47ce9ad | |
| ToppCell | COVID-19_Severe|World / Disease condition and Cell class | 2.12e-07 | 196 | 58 | 6 | 450ac2aff89c5ca73b8bfbc80663e03be066931f | |
| ToppCell | hematopoetic_progenitors-CD34+_HSC|hematopoetic_progenitors / Lineage and Cell class | 2.12e-07 | 196 | 58 | 6 | d3e20212c15cff0a3c4e23e8b94715b5822a43e2 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.12e-07 | 196 | 58 | 6 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.19e-07 | 197 | 58 | 6 | 434a5686a103bb766e0d80038413f0e12ea3981a | |
| ToppCell | Mild_COVID-19-T/NK-proliferating_T/NK|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 2.19e-07 | 197 | 58 | 6 | 5fd52fba2cb6fa67377f873da2ff6ce9c83b0591 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.19e-07 | 197 | 58 | 6 | 6bddfa199ca812d9e518eaa02c3d4fb67e9f5b16 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.19e-07 | 197 | 58 | 6 | c0a71a9452febda433bc544e4ac0a79c43dcf13e | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-07 | 198 | 58 | 6 | ac0be1666456cfa8d68588b187d65008e6d5c0e2 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-07 | 198 | 58 | 6 | d484ac79d6cd29f1d9c192d126c2099f737d5320 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-Immature_CFuPNs|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.26e-07 | 102 | 58 | 5 | f1d960a227a741e568831974c2a7f4b3e6bc9957 | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-vRG-17|World / Primary Cells by Cluster | 2.39e-07 | 200 | 58 | 6 | 4417f14d45ce683c1a45ec989ae63ee6c047353e | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.00e-07 | 128 | 58 | 5 | 9ab55a0421cd970e0b8dabce67dd68e382a6bd41 | |
| ToppCell | moderate-Epithelial-unknown_epithelial|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.55e-07 | 130 | 58 | 5 | a04057bd4f256d09eca06b8c1e8b41425bb4ef3f | |
| ToppCell | PCW_13-14-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-im_megakaryocyte1_(20)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.98e-06 | 158 | 58 | 5 | 944c5fe625f965dd6153dbcbf5577f99ad343983 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Plasmacytoid_Dendritic_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.23e-06 | 162 | 58 | 5 | 9dca585c734faea0e1122c70f5dc36cef3dbd2c6 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.44e-06 | 165 | 58 | 5 | 26c750f10f6401752e2e63d91dc844c81b29d735 | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-stalk_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.44e-06 | 165 | 58 | 5 | 4297588f809e8a8275ab1a6ed99daac7ad93bd61 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.59e-06 | 167 | 58 | 5 | 754e6412d3b9cc0b126e59593df2f5956b4712ef | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.4.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.83e-06 | 170 | 58 | 5 | cf22a843ae2d9cd6693507fed2b7c6a45abea10e | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.17e-06 | 174 | 58 | 5 | 021ebc6ec022b992d7b25333ba0b7416371e041b | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.17e-06 | 174 | 58 | 5 | 723848d2f8ae9cf4f15d4b4a130f9a64dab443c7 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.17e-06 | 174 | 58 | 5 | c2fc78dd6c440737ded59676961e4c7b923084ce | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_goblet_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.45e-06 | 177 | 58 | 5 | a4c001a8e44142babf9f24dfe6f7b73a70b11b16 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_goblet_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.45e-06 | 177 | 58 | 5 | 363e07b0f347f3716d530a28ead854b98e27d37c | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.64e-06 | 179 | 58 | 5 | b88791dd4e73bb8410ca090938a1a45b0bc16e69 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.64e-06 | 179 | 58 | 5 | c063028b82c68d929aef2421daade9dc189a6963 | |
| ToppCell | COVID-19_Mild|World / Disease Group and Platelet Clusters | 3.95e-06 | 182 | 58 | 5 | 90c61e10c7860bfba6ccfe6f37671c8924637f7b | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-06 | 183 | 58 | 5 | 769a022fe8568ec49e66f792cc5777e713a7571c | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-06 | 183 | 58 | 5 | aac0695fafa59cabd920ee18b1139d3e00d898e8 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.16e-06 | 184 | 58 | 5 | 01c19a830348ab0b9c02c1546a439de70ee10f97 | |
| ToppCell | Dividing_Macrophages-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 4.16e-06 | 184 | 58 | 5 | f15ce786d25c6546804a6d1efcc2ad645f2ef54e | |
| ToppCell | PBMC-Severe-Hematopoietic-Platelet-Platelet-plt_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.28e-06 | 185 | 58 | 5 | 698ff44fd2d9b3ad5cea45f4cff9bfc64c559b62 | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_progenitors-Progenitor_pre-Lymphocytic-T|lymph-node_spleen / Manually curated celltypes from each tissue | 4.39e-06 | 186 | 58 | 5 | 17eec1efad1f5e9ced1eb6bc9eb5dd7ded789c61 | |
| ToppCell | PBMC-Severe-Hematopoietic-Platelet-Platelet-plt_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.39e-06 | 186 | 58 | 5 | 981116561986f94e9cc3ee64fb37dab9a31d427a | |
| ToppCell | MatrixFB-Fibroblast-E_(Early_Fibroblastic_progenitor)|MatrixFB / shred on cell class and cell subclass (v4) | 4.62e-06 | 188 | 58 | 5 | b240ea20750ffb825cb5fe41d06c632233406ab6 | |
| ToppCell | Fibroblast-E_(Early_Fibroblastic_progenitor)|World / shred on cell class and cell subclass (v4) | 4.62e-06 | 188 | 58 | 5 | be3db9768364568f44e32ae6b3bf99e49b0978bb | |
| ToppCell | B_cells-Plasmablasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 4.75e-06 | 189 | 58 | 5 | 87cb7b6ba9fd57100d68e6eaeecd1ac6ab22d1c6 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.87e-06 | 190 | 58 | 5 | 185ae04c68f825cd346aa65072cc5da6a39dff4a | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.87e-06 | 190 | 58 | 5 | 7de42d8572599693618fb920798a2e52a0b5265c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.87e-06 | 190 | 58 | 5 | e38dc41f2e79e3bd51326581c6ebe51927edb549 | |
| ToppCell | Endothelial-D_(cycle)|World / shred on cell class and cell subclass (v4) | 4.99e-06 | 191 | 58 | 5 | 49a4d8f181558e3be9527a8ff9a178f3bb01323c | |
| ToppCell | Endothelial-Endothelial-D_(cycle)|Endothelial / shred on cell class and cell subclass (v4) | 4.99e-06 | 191 | 58 | 5 | a3c5a913a99f17633c140ec9ece81b73e59e0715 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.99e-06 | 191 | 58 | 5 | 0f9443da0f73d07456142fae08b2dc92a5b7b592 | |
| ToppCell | 3'_v3-bone_marrow|World / Manually curated celltypes from each tissue | 4.99e-06 | 191 | 58 | 5 | 7b759831f1b1c8575c31f67d0d9eb11c6a833cf3 | |
| ToppCell | Mild/Remission-B_naive-11|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.12e-06 | 192 | 58 | 5 | c6f325cddce43b72f013b21dfffc9987fd68b6a7 | |
| ToppCell | Control-Lymphoid-Proliferating_CD4_T_cells|Control / Condition, Lineage and Cell class | 5.25e-06 | 193 | 58 | 5 | 33d409d6ed1c606337248587ad997ac5f67f081d | |
| ToppCell | mild_COVID-19_(asymptomatic)-Platelet|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 5.25e-06 | 193 | 58 | 5 | 9b97a7e9b5c1cc5db353070af0b9c5059714724b | |
| ToppCell | COVID-19_Mild-PLT_4|World / Disease Group and Platelet Clusters | 5.25e-06 | 193 | 58 | 5 | 98a52523aa1efd5d14a2878ed106828a80a33aa2 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.25e-06 | 193 | 58 | 5 | ecbe1bd16df547427da5e69a3017300e766c2899 | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-B-Pro-B|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.39e-06 | 194 | 58 | 5 | 58d7c56d2b9c893b62da2334428d677e3451fe07 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.52e-06 | 195 | 58 | 5 | 79114b3c78cc15c413bb58f0673e7215b784a9b6 | |
| ToppCell | Biopsy_Control_(H.)-Immune-pDCs|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 5.52e-06 | 195 | 58 | 5 | 47d139215f0b51f5ea9b5fb09b1100e320e3f1e2 | |
| ToppCell | moderate-Epithelial-IRC-IFNG_responsive_cell|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.52e-06 | 195 | 58 | 5 | 4ea79451b9c040650a74831b64a41d36b180ac0f | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.66e-06 | 196 | 58 | 5 | 4924a36a81d62863c1004b8c76f8096a1f89c548 | |
| ToppCell | 3'-Adult-LargeIntestine|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.81e-06 | 197 | 58 | 5 | 03646005921bc330b7a9f66889ef1a7b9a3d530e | |
| ToppCell | COVID-19_Severe|World / Disease group, lineage and cell class | 5.81e-06 | 197 | 58 | 5 | f0824f98269bdcd8463873beaf222df8f0caa468 | |
| ToppCell | severe-unassigned|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.81e-06 | 197 | 58 | 5 | 70704b149b2820b8601d2495b7cd9cbe91eda262 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.81e-06 | 197 | 58 | 5 | f34b1e34f1f0694564031077172c890b233ce8b7 | |
| ToppCell | distal-Hematologic-Proliferating_NK/T-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.81e-06 | 197 | 58 | 5 | 04b10879e48c101d1de449db0bc6b6484090b965 | |
| ToppCell | PBMC-Severe|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.81e-06 | 197 | 58 | 5 | af10b5e6e959e2ced01ad066f906941bc4194cc3 | |
| ToppCell | PBMC-Severe|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.81e-06 | 197 | 58 | 5 | 3ff23b86d310ace388d2efb3ee73dd47c46f363e | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.81e-06 | 197 | 58 | 5 | d7a9296092153cf66426911fecd810f0c1ef978e | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.81e-06 | 197 | 58 | 5 | dcff23240bb7cb652d7426b29355aa74442ef6fc | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.95e-06 | 198 | 58 | 5 | 2445c9ff8e3f69314bdcb04faf7735272b916242 | |
| ToppCell | (5)_Dendritic_cell-(53)_Lymphoid_DC|(5)_Dendritic_cell / shred on Cell_type and subtype | 5.95e-06 | 198 | 58 | 5 | 548da5fa86f9756c503ed77bcdde55bc4d1a2726 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.95e-06 | 198 | 58 | 5 | 6981cd5b1585c8ae6febdf0c4fb83067127f106c | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Early_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.10e-06 | 199 | 58 | 5 | d67f5ae05daf942fb79f5b962021f37f4e275f4d | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-epithelial_progenitor_cell-TA|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.10e-06 | 199 | 58 | 5 | 0649a2c5b8b1f01bb4c4d1eb114cf78a32f8ccd8 | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-epithelial_progenitor_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.10e-06 | 199 | 58 | 5 | e3e28981783b922027cee7fe8863386b02c7c758 | |
| ToppCell | NS-critical-d_16-33-Lymphoid-NKT-proliferating|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.10e-06 | 199 | 58 | 5 | 31b144bb209c629e12156f4d9c9cec79baffffb9 | |
| ToppCell | Non-neuronal-Dividing|World / Primary Cells by Cluster | 6.25e-06 | 200 | 58 | 5 | 50fa7b34a05f2c5ebbc7d113bd8e31326688a231 | |
| ToppCell | NS-critical-d_07-13-Lymphoid-NKT-proliferating|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.25e-06 | 200 | 58 | 5 | 7f5cd05bb1b9a83baceddb7d7f0a9ec9781cda29 | |
| ToppCell | severe|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.25e-06 | 200 | 58 | 5 | accc618d6b960bff30cb531c1226295bfc8650f6 | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-vRG|World / Primary Cells by Cluster | 6.25e-06 | 200 | 58 | 5 | 7596143925cd403ec7baceef87d19d570e48586a | |
| ToppCell | severe-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.25e-06 | 200 | 58 | 5 | 6aa77955017d073a96324e4db6b9950a2ec46cf8 | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-NKT-proliferating|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.25e-06 | 200 | 58 | 5 | 7b7a5800798a3e7eba164fbc28312dd09c57a2c3 | |
| ToppCell | moderate-Lymphoid-NKT-proliferating|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.25e-06 | 200 | 58 | 5 | 8692e6664f0bb2be990f7563888380bb47414626 | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia|World / Primary Cells by Cluster | 6.25e-06 | 200 | 58 | 5 | ecbbad00e16041a9e1cd88d8bd7279a1b52c0aa4 | |
| Computational | Genes in the cancer module 203. | 5.23e-14 | 16 | 39 | 7 | MODULE_203 | |
| Computational | Genes in the cancer module 90. | 8.88e-14 | 17 | 39 | 7 | MODULE_90 | |
| Computational | Genes in the cancer module 189. | 1.10e-12 | 23 | 39 | 7 | MODULE_189 | |
| Computational | Genes in the cancer module 127. | 2.93e-12 | 26 | 39 | 7 | MODULE_127 | |
| Computational | Genes in the cancer module 89. | 4.48e-12 | 14 | 39 | 6 | MODULE_89 | |
| Computational | Chromatin and nucleosomes. | 2.74e-11 | 18 | 39 | 6 | MODULE_552 | |
| Computational | Genes in the cancer module 168. | 1.09e-10 | 22 | 39 | 6 | MODULE_168 | |
| Computational | Genes in the cancer module 222. | 1.09e-10 | 22 | 39 | 6 | MODULE_222 | |
| Computational | Chromatin. | 5.42e-10 | 28 | 39 | 6 | MODULE_421 | |
| Computational | Genes in the cancer module 534. | 3.99e-09 | 18 | 39 | 5 | MODULE_534 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.02e-05 | 50 | 39 | 4 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Computational | Genes in the cancer module 17. | 3.00e-04 | 366 | 39 | 7 | MODULE_17 | |
| Computational | rRNA processing and DNA repair. | 1.89e-03 | 18 | 39 | 2 | MODULE_392 | |
| Drug | N-myristoyl-rkrtlrrl | 2.04e-15 | 46 | 57 | 9 | CID003081274 | |
| Drug | CAS 1400-61-9 | 8.11e-15 | 53 | 57 | 9 | CID000004568 | |
| Drug | 5-methyl-dCTP | 1.16e-14 | 55 | 57 | 9 | CID000161376 | |
| Drug | SK-7041 | 2.67e-14 | 60 | 57 | 9 | CID006918714 | |
| Drug | AlCl3 | 2.15e-13 | 113 | 57 | 10 | CID000024012 | |
| Drug | C04378 | 5.07e-13 | 82 | 57 | 9 | CID000440315 | |
| Drug | butyrolactone I | 7.62e-13 | 128 | 57 | 10 | CID000123740 | |
| Drug | AC1OCADI | 8.92e-13 | 130 | 57 | 10 | CID006914639 | |
| Drug | 8-bromoguanosine | 1.63e-12 | 93 | 57 | 9 | CID000092977 | |
| Drug | cytosine | PPP1R10 H2BC17 H2BC21 MBD1 H1-0 H1-2 H1-3 H1-4 H1-5 APC H1-1 MACROH2A2 HP1BP3 GABRA3 | 3.07e-12 | 441 | 57 | 14 | CID000000597 |
| Drug | 3-tert-butylphenyl-N-methyl-carbamate | 3.32e-12 | 36 | 57 | 7 | CID000013072 | |
| Drug | heparin disaccharide iii-S | 4.09e-12 | 37 | 57 | 7 | CID000448838 | |
| Drug | mustard oil | 1.06e-11 | 114 | 57 | 9 | CID000005971 | |
| Drug | DB08184 | 1.10e-11 | 167 | 57 | 10 | CID009547945 | |
| Drug | 5-methylcytosine | H2BC17 H2BC21 MBD1 H1-0 H1-2 H1-3 H1-4 H1-5 APC H1-1 MACROH2A2 | 1.24e-11 | 233 | 57 | 11 | CID000065040 |
| Drug | Spkk | 1.26e-11 | 43 | 57 | 7 | CID000129363 | |
| Drug | GH 5 | 1.77e-11 | 45 | 57 | 7 | CID000163897 | |
| Drug | NaBu | 1.96e-11 | 122 | 57 | 9 | CID000052923 | |
| Drug | Scriptaid | 2.86e-11 | 48 | 57 | 7 | CID000005186 | |
| Drug | DADS | 3.73e-11 | 131 | 57 | 9 | CID000016590 | |
| Drug | belinostat | 3.87e-11 | 50 | 57 | 7 | CID006918638 | |
| Drug | chlorambucil | 4.27e-11 | 133 | 57 | 9 | CID000002708 | |
| Drug | NSC-629231 | 7.78e-11 | 55 | 57 | 7 | CID000363885 | |
| Drug | 3-aminobenzamide | 1.79e-10 | 156 | 57 | 9 | CID000001645 | |
| Drug | gold sodium thiomalate | 1.86e-10 | 62 | 57 | 7 | CID000022318 | |
| Drug | Anisomycin [22862-76-6]; Up 200; 15uM; MCF7; HT_HG-U133A | 2.25e-10 | 160 | 57 | 9 | 5364_UP | |
| Drug | gamma-butyrolactone | 2.68e-10 | 108 | 57 | 8 | CID000007302 | |
| Drug | CGP 41251 | 2.68e-10 | 108 | 57 | 8 | CID000104937 | |
| Drug | LBH589 | 2.89e-10 | 109 | 57 | 8 | CID006918837 | |
| Drug | F2-b | 2.92e-10 | 66 | 57 | 7 | CID000001700 | |
| Drug | syntide-2 | 4.94e-10 | 71 | 57 | 7 | CID005074902 | |
| Drug | gossypol | 5.20e-10 | 247 | 57 | 10 | CID000003503 | |
| Drug | Methylmethacrylate | 5.75e-10 | 39 | 57 | 6 | ctd:D020366 | |
| Drug | Cycloheximide [66-81-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 5.80e-10 | 178 | 57 | 9 | 6220_UP | |
| Drug | butane | 7.63e-10 | 123 | 57 | 8 | CID000007843 | |
| Drug | hydralazine | 8.57e-10 | 186 | 57 | 9 | CID000003637 | |
| Drug | procainamide | 1.03e-09 | 190 | 57 | 9 | CID000004913 | |
| Drug | Trapoxin B | 1.06e-09 | 79 | 57 | 7 | CID000005532 | |
| Drug | MgCl2 | NEFH H2BC17 H2BC21 MYO9B H1-0 H1-2 H1-3 H1-4 H1-5 H1-1 MACROH2A2 | 1.07e-09 | 354 | 57 | 11 | CID000024584 |
| Drug | AC1L9M5N | 1.42e-09 | 133 | 57 | 8 | CID000448618 | |
| Drug | LAQ824 | 3.13e-09 | 92 | 57 | 7 | CID006445533 | |
| Drug | polyarginine | 3.92e-09 | 95 | 57 | 7 | CID000072364 | |
| Drug | NSC23766 | 4.88e-09 | 98 | 57 | 7 | CID000409805 | |
| Drug | AC1L1FWN | 4.93e-09 | 227 | 57 | 9 | CID000003425 | |
| Drug | Pe v | 7.47e-09 | 164 | 57 | 8 | CID005326793 | |
| Drug | gibberellin (GA | 8.22e-09 | 166 | 57 | 8 | CID000006466 | |
| Drug | In-G | 9.91e-09 | 170 | 57 | 8 | CID000446054 | |
| Drug | Cycloheximide [66-81-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 1.14e-08 | 173 | 57 | 8 | 3464_UP | |
| Drug | W7 hydrochloride | 1.14e-08 | 250 | 57 | 9 | CID000005681 | |
| Drug | Apicidin | 1.32e-08 | 113 | 57 | 7 | CID000467801 | |
| Drug | NSC611747 | 1.56e-08 | 352 | 57 | 10 | CID000002534 | |
| Drug | zinc chloride (ZnCl2 | 2.00e-08 | 186 | 57 | 8 | CID000005727 | |
| Drug | Kemptide | 2.53e-08 | 124 | 57 | 7 | CID000100074 | |
| Drug | fluoride | 2.86e-08 | 278 | 57 | 9 | CID000014917 | |
| Drug | Berberine | 3.80e-08 | 202 | 57 | 8 | ctd:D001599 | |
| Drug | AC1L45LU | 4.26e-08 | 205 | 57 | 8 | CID000151069 | |
| Drug | Amphoterin | 5.56e-08 | 139 | 57 | 7 | CID003496889 | |
| Drug | myristate | 7.26e-08 | 310 | 57 | 9 | CID000011005 | |
| Drug | MS-275 | 8.97e-08 | 149 | 57 | 7 | CID000004261 | |
| Drug | NSC759587 | H2BC17 H2BC21 H1-0 H1-2 H1-3 H1-4 H1-5 H1-1 MACROH2A2 GABRA3 | 1.37e-07 | 444 | 57 | 10 | CID000003816 |
| Drug | DNA methyltransferase inhibitor | 1.46e-07 | 160 | 57 | 7 | CID000344265 | |
| Drug | Cephaeline dihydrochloride heptahydrate [6487-30-5]; Up 200; 6uM; MCF7; HT_HG-U133A | 1.88e-07 | 166 | 57 | 7 | 3290_UP | |
| Drug | arsenite | 1.89e-07 | 347 | 57 | 9 | CID000000544 | |
| Drug | Emetine dihydrochloride [316-42-7]; Up 200; 7.2uM; MCF7; HT_HG-U133A | 2.04e-07 | 168 | 57 | 7 | 2801_UP | |
| Drug | Cephaeline dihydrochloride heptahydrate [6487-30-5]; Up 200; 6uM; MCF7; HT_HG-U133A | 2.30e-07 | 171 | 57 | 7 | 5247_UP | |
| Drug | Cycloheximide [66-81-9]; Up 200; 14.2uM; HL60; HT_HG-U133A | 2.30e-07 | 171 | 57 | 7 | 2723_UP | |
| Drug | NSC351140 | 2.49e-07 | 258 | 57 | 8 | CID000002210 | |
| Drug | SN-38 | 3.78e-07 | 184 | 57 | 7 | CID000104842 | |
| Drug | A25618 | H2BC17 H2BC21 MBD1 H1-0 H1-2 H1-3 H1-4 H1-5 H1-1 MACROH2A2 ADD3 HP1BP3 | 3.95e-07 | 777 | 57 | 12 | CID000005562 |
| Drug | valproate | 4.15e-07 | 381 | 57 | 9 | CID000003121 | |
| Drug | nalidixic acid | 4.28e-07 | 277 | 57 | 8 | CID000004421 | |
| Drug | AC1Q6AQ7 | 4.37e-07 | 188 | 57 | 7 | CID000005515 | |
| Drug | 5-aza-2'-deoxycytidine | H2BC17 H2BC21 MBD1 H1-0 H1-2 H1-3 H1-4 H1-5 APC H1-1 MACROH2A2 | 4.39e-07 | 638 | 57 | 11 | CID000016886 |
| Drug | spermine | 5.49e-07 | 394 | 57 | 9 | CID000001103 | |
| Drug | Mycophenolic acid [24280-93-1]; Down 200; 12.4uM; PC3; HT_HG-U133A | 5.59e-07 | 195 | 57 | 7 | 4019_DN | |
| Drug | BM-11 | 6.91e-07 | 28 | 57 | 4 | CID003036083 | |
| Drug | phosphatidate | 1.18e-06 | 432 | 57 | 9 | CID005460104 | |
| Drug | propranolol | 1.22e-06 | 434 | 57 | 9 | CID000004946 | |
| Drug | hydroxyurea | 1.27e-06 | 436 | 57 | 9 | CID000003657 | |
| Drug | Ro 31-8220 | 1.30e-06 | 321 | 57 | 8 | CID000005083 | |
| Drug | AC1L9DEH | 1.32e-06 | 569 | 57 | 10 | CID000442783 | |
| Drug | 4-PBA | 1.41e-06 | 224 | 57 | 7 | CID000004775 | |
| Drug | glycogen | 1.45e-06 | 443 | 57 | 9 | CID000439177 | |
| Drug | B on A | 2.12e-06 | 464 | 57 | 9 | CID000007104 | |
| Drug | sodium butyrate | 2.17e-06 | 344 | 57 | 8 | CID005222465 | |
| Drug | arsenic trioxide | 2.28e-06 | 468 | 57 | 9 | CID000014888 | |
| Drug | Zlllal | 2.57e-06 | 613 | 57 | 10 | CID000107707 | |
| Drug | butyrate | H2BC17 H2BC21 H1-0 H1-2 H1-3 H1-4 H1-5 APC H1-1 MACROH2A2 GABRA3 | 2.65e-06 | 767 | 57 | 11 | CID000000264 |
| Drug | AC1L9HHR | 2.68e-06 | 354 | 57 | 8 | CID000445141 | |
| Drug | S-adenosylmethionine | 2.74e-06 | 355 | 57 | 8 | CID000001079 | |
| Drug | Mefloquine hydrochloride [51773-92-3]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 2.96e-06 | 160 | 57 | 6 | 2210_UP | |
| Drug | spermidine | 3.17e-06 | 253 | 57 | 7 | CID000001102 | |
| Drug | AC1Q5HK6 | 3.96e-06 | 501 | 57 | 9 | CID000003640 | |
| Drug | propionate | 3.99e-06 | 262 | 57 | 7 | CID000001032 | |
| Drug | Cephaeline dihydrochloride heptahydrate [6487-30-5]; Up 200; 6uM; MCF7; HT_HG-U133A | 4.64e-06 | 173 | 57 | 6 | 5612_UP | |
| Drug | ADP-Rib | 4.75e-06 | 269 | 57 | 7 | CID000000192 | |
| Drug | Felodipine [72509-76-3]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 4.96e-06 | 175 | 57 | 6 | 3295_UP | |
| Drug | AC1Q68Z5 | 5.08e-06 | 386 | 57 | 8 | CID000000181 | |
| Drug | ara-AC | 6.03e-06 | 279 | 57 | 7 | CID000001805 | |
| Drug | LY 294002; Up 200; 10uM; HL60; HT_HG-U133A | 6.62e-06 | 184 | 57 | 6 | 2696_UP | |
| Disease | Inguinal hernia | 1.34e-06 | 287 | 57 | 7 | HP_0000023 | |
| Disease | spastic quadriplegic cerebral palsy 3 (implicated_via_orthology) | 1.10e-05 | 3 | 57 | 2 | DOID:0081361 (implicated_via_orthology) | |
| Disease | cerebral palsy (implicated_via_orthology) | 1.63e-04 | 10 | 57 | 2 | DOID:1969 (implicated_via_orthology) | |
| Disease | transferrin receptor protein 1 measurement | 3.29e-04 | 14 | 57 | 2 | EFO_0802142 | |
| Disease | birth weight | 1.04e-03 | 399 | 57 | 5 | EFO_0004344 | |
| Disease | Hypermetropia | 1.05e-03 | 103 | 57 | 3 | HP_0000540 | |
| Disease | glycoprotein measurement | 1.60e-03 | 119 | 57 | 3 | EFO_0004555 | |
| Disease | liver iron measurement | 1.86e-03 | 33 | 57 | 2 | EFO_0010056 | |
| Disease | guilt measurement | 2.73e-03 | 40 | 57 | 2 | EFO_0009595 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 3.20e-03 | 152 | 57 | 3 | DOID:0060041 (implicated_via_orthology) | |
| Disease | autism spectrum disorder, schizophrenia | 3.69e-03 | 327 | 57 | 4 | EFO_0003756, MONDO_0005090 | |
| Disease | mean reticulocyte volume | 4.34e-03 | 799 | 57 | 6 | EFO_0010701 | |
| Disease | Malignant neoplasm of breast | 4.49e-03 | 1074 | 57 | 7 | C0006142 | |
| Disease | cerebellar volume measurement | 4.57e-03 | 52 | 57 | 2 | EFO_0020864 | |
| Disease | response to calcium channel blocker | 5.28e-03 | 56 | 57 | 2 | EFO_0007767 | |
| Disease | smoking status measurement | 6.79e-03 | 1160 | 57 | 7 | EFO_0006527 | |
| Disease | white matter microstructure measurement | 6.84e-03 | 390 | 57 | 4 | EFO_0005674 | |
| Disease | Schizophrenia | 7.00e-03 | 883 | 57 | 6 | C0036341 | |
| Disease | optic disc size measurement | 7.34e-03 | 205 | 57 | 3 | EFO_0004832 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SPSKKKKKFRTPSFL | 681 | Q9UEY8 | |
| TSAPAAKPKRAKASK | 6 | P07305 | |
| KVATPKKASKPKKAA | 116 | P07305 | |
| KKASKPKKAASKAPT | 121 | P07305 | |
| AATPKKAKKPKTVKA | 151 | P07305 | |
| AKPVKPKAKSSAKRA | 176 | P07305 | |
| KPAKAAAASKKKPAG | 26 | Q02539 | |
| KTPKKAKKPAATRKS | 151 | Q02539 | |
| AKKPAATRKSSKNPK | 156 | Q02539 | |
| ATRKSSKNPKKPKTV | 161 | Q02539 | |
| AKSPAKAKAVKPKAA | 181 | Q02539 | |
| KAKAVKPKAAKARVT | 186 | Q02539 | |
| KPKAAKARVTKPKTA | 191 | Q02539 | |
| KARVTKPKTAKPKKA | 196 | Q02539 | |
| AAKPRTSKKSKPKDS | 151 | Q9P0M6 | |
| AKKTPKKAKKPAAAT | 151 | P16403 | |
| KPKKAAKSAAKAVKP | 181 | P16403 | |
| AKSAAKAVKPKAAKP | 186 | P16403 | |
| KKKSKPPEKKSSRNY | 261 | Q86XR8 | |
| KKTPVRSTPKEIKKA | 126 | A0A1B0GVH6 | |
| KKPAKSKPAVSRDKA | 931 | Q9Y2H0 | |
| KSAPAPKKGSKKAVT | 6 | P57053 | |
| KAKKRKSDKNPNSPR | 151 | Q14CW9 | |
| RATKPKKAPKREKSA | 81 | Q8N436 | |
| KKAPPKAKTPAKKTR | 496 | Q5SSJ5 | |
| RPLSQEPAKKVKAKK | 96 | P42696 | |
| KSAPAPKKGSKKAVT | 6 | Q16778 | |
| KSAPAPKKGSKKAVT | 6 | Q5QNW6 | |
| KSAPAPKKGSKKAVT | 6 | P06899 | |
| KSAPAPKKGSKKAVT | 6 | Q99877 | |
| KFAPAPKKGSKKAVT | 6 | Q6DN03 | |
| KFAPAPKKGSKKAVT | 6 | Q6DRA6 | |
| RVTKPCTPKTKAKAK | 121 | P21741 | |
| AESPEKKPACRKKKT | 216 | A6NHT5 | |
| KAPKKKSIKSSIGRL | 756 | O75145 | |
| TKPVAKESKAEPKAK | 596 | Q9HDC5 | |
| KSAPAPKKGSKKAVT | 6 | P58876 | |
| KSAPAPKKGSKKAVT | 6 | Q93079 | |
| KSAPAPKKGSKKAVT | 6 | O60814 | |
| VASKKRKKPSRPAKT | 81 | Q9UIS9 | |
| KAPAAPKTPSKAKKN | 1691 | Q9P2S2 | |
| PLTGKKKRKSPFAAA | 471 | Q8N9T8 | |
| KKKTPAAPAKKTSTT | 381 | P34903 | |
| APAAPKTPSKAKKNK | 646 | P58401 | |
| AKSPEKAKSPEKAKS | 646 | P12036 | |
| KAKSPVKAEAKSPEK | 671 | P12036 | |
| KSPEKAKSPVKAEAK | 681 | P12036 | |
| KAEAKSPEKAKSPVK | 691 | P12036 | |
| KSAPAPKKGSKKAVT | 6 | P62807 | |
| KSAPAPKKGSKKAVT | 6 | Q8N257 | |
| AVKKTPKKAKKPAAA | 151 | P16401 | |
| KPAAAGVKKVAKSPK | 161 | P16401 | |
| KAKAAAKPKKATKSP | 176 | P16401 | |
| ATKSPAKPKAVKPKA | 186 | P16401 | |
| LKPVSCPKSKASDKR | 156 | Q96M89 | |
| KSAPAPKKGSKKAVT | 6 | Q99880 | |
| KSAPAPKKGSKKAVT | 6 | P23527 | |
| AKKTPKKAKKPAAAA | 151 | P10412 | |
| PAAAAGAKKAKSPKK | 161 | P10412 | |
| KSPAKAKAVKPKAAK | 186 | P10412 | |
| AKAVKPKAAKPKTAK | 191 | P10412 | |
| PQPKKAAKSPAKAKA | 181 | P16402 | |
| AAKSPAKAKAPKPKA | 186 | P16402 | |
| SPVKKAKATARAKKP | 196 | Q86SE8 | |
| PAKAVKAPGAKKPKA | 211 | Q01101 | |
| SPTPKSKRKSKDKKR | 231 | Q9UQ35 | |
| SKSISLRKAKKKPSP | 556 | Q5HYW2 | |
| APPKAEAKAKALKAK | 11 | P62750 | |
| SPSKKKKKFRTPSFL | 701 | P35612 | |
| SAMPTKSSRKAKKPA | 1581 | P25054 | |
| AAKKSPKISRASKSP | 526 | Q9NRJ4 | |
| ASKPAKKKPVSKHEL | 166 | O95625 | |
| KKPNKSKRSKTPVQA | 1816 | Q96T58 | |
| FHSPKIKRTPSKKGK | 21 | Q13905 | |
| SVVAIRPKKSKGKKA | 291 | Q12816 | |
| SRSKKPSKKPSGKSA | 136 | O15391 | |
| IKAKRKPSASSKPSL | 231 | Q9Y2X9 | |
| SRAKGIPKKKKAVSF | 41 | Q9UJT2 | |
| PQKKTSKRPSSSKKA | 481 | Q9UGU0 | |
| DPALKSRPKKKKNSD | 861 | Q9UPP1 | |
| AASRKRKKPKEKAQP | 1416 | Q5T5U3 | |
| KKKKKVLSPTAAKPS | 306 | Q96QC0 | |
| RSAKKPAVQKKKPGD | 1381 | Q13459 |